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This thesis examines the psychological factors involved in distress and wellbeing for 
people living with dystonia. 
Section one reports on a systematic literature review of quantitative studies examining 
the relationship between psychological factors and anxiety and depression in dystonia. A 
systematic search using key words relating to dystonia and concepts of psychological distress 
was conducted on four academic databases. Findings suggest that a number of psychological 
factors were related to anxiety and depression in dystonia.  These included body concept, 
coping, personality traits, self-esteem, psychosocial domains of quality of life, and somatic 
complaints. The limited number of papers suggests that psychological factors are an under 
researched area when understanding the distress experienced in dystonia; nonetheless, the 
findings support  a biopsychosocial model of understanding. This has clinical implications for 
the psychological management of distress for those living with dystonia and future research 
should seek to expand on this knowledge.  
 Section two reports on an empirical study examining the role of coping strategies in 
the relationship between stigma and psychological wellbeing in people living with cervical 
dystonia. Individuals with cervical dystonia completed an online survey including measures 
of stigma, coping strategies, quality of life, psychological distress and wellbeing. A series of 
parallel mediation models were conducted to explore the relationships between stigma, 
coping strategies and distress and wellbeing. Findings indicated that maladaptive coping 
strategies mediated the relationship between stigma and psychological distress and wellbeing.  
Adaptive coping strategies did not mediate the relationship between stigma and psychological 
distress and wellbeing.  These findings support the need for holistic psychological 
formulations for individuals with cervical dystonia who are also experiencing psychological 
distress. 
 iv 
 Section three includes the critical appraisal which reflected on the process of 
conducting this project.  It discusses key decision points and critically evaluates some of the 
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Abstract 
Purpose: Individuals with dystonia often experience depression and anxiety at higher rates than 
the general population. There is debate over whether these are primary symptoms of dystonia or 
secondary in response to living with a chronic health condition. The aim of this paper was to 
review psychological correlates of anxiety and depression for those living with dystonia. 
Methods: PsycINFO, MEDLINE, CINAHL, and Web of Science databases were systematically 
searched for eligible studies using keywords related to ‘dystonia’ and ‘anxiety/depression’. 
Quantitative studies which analysed the relationship between psychological factors and anxiety 
or depression were included. Quality assessment was conducted on all eligible studies.  
Results: 16 studies were included in this review. Psychological correlates of anxiety and 
depression examined were body concept, coping, personality traits, self-esteem, psychosocial 
domains of QoL, self-efficacy and somatic complaints. In addition, some factors seemed to 
interact with each other to influence the overall measures of depression and anxiety. Other 
factors included in singular studies were locus of control, social support, sexual wellbeing, 
substance abuse and psychological symptoms as measured by the SCL-90.  
Conclusion: The literature reviewed revealed limited research had been done in this area. What 
had been examined highlighted a number of different factors relating to distress for those living 
with dystonia. This supports a biopsychosocial understanding of the development of anxiety and 
depression. This has clinical implications for the psychological management of distress for 
individuals. Future research should explore the relationships between these factors using 
longitudinal designs and more complex statistical models.  
Keywords:  dystonia; anxiety; depression; movement disorders; psychology 
 
PSYCHOLOGICAL CORRELATES OF DISTRESS IN DYSTONIA  1-3 
Introduction 
Dystonia is a movement disorder characterised by involuntary intermittent or sustained 
contraction of muscles causing abnormal postures, tremors and twisting. These are often initiated 
or made worse by voluntary action (1). It is the third most prevalent movement disorder after 
Parkinson’s disease and essential tremor (2) and the presentations of dystonia are wide ranging 
and varied (3). It has been proposed that dystonia be classified on two axes (4). Axis I specifies 
clinical characteristics such as age of onset, body distribution (focal, segmental, multifocal, 
generalised, hemidystonia), temporal pattern (disease course and variability) and associated 
features. Axis II specifies aetiology, stating whether the dystonia is inherited or acquired, 
idiopathic and any evidence of central nervous system pathology.   
Due to the varied expression of the disease it is difficult to accurately assess current 
prevalence. Published epidemiological studies have estimated 15-30 cases of primary dystonia 
per 100,000 of the population (5,6), although this is likely to be an underestimation (1) as 
dystonia is often misdiagnosed or unrecognised (7). Indeed, a study investigating the prevalence 
of dystonia in the general community reported that it may be as high as 732 cases per 100,000 of 
the population, with only a small proportion of those identified having received an official 
diagnosis prior to the study taking place (8). Adult onset focal dystonias are the most common 
presentations (1) and within this category the most frequent types are cervical dystonia (CD, 
affecting the muscles of the neck and shoulders) and blepharospasm (affecting the eyes). Other 
presentations such as spasmodic dysphonia (SD, affecting the larynx) and writer’s or musician’s 
cramp (affecting the hand) are rarer (3). 
People living with dystonia have been shown to experience high rates of psychological 
distress including depression, anxiety and social anxiety (1,9), with prevalence rates of between 
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12%-71% (10–15) compared to between 10%-20% in the general population of the UK (16). A 
recent study examined if type of dystonia had an impact on distress experienced (17). They 
found no difference between groups on measures of depression, but those with CD and SD 
scored higher than other focal types of dystonia on measures of anxiety. Additionally, those with 
SD scored higher than the other groups on measures of social anxiety. 
The pathophysiology of dystonia is still not fully understood (3) and the underlying 
reason for the rates of psychological distress is under debate. There is evidence that, for some, 
psychological distress precedes the onset of dystonia motor symptoms (18–20) with this 
occurring in as many as 69% of participants in one sample (12).  There have also been reductions 
in psychological distress following successful treatment with botulinum toxin injections or deep 
brain stimulation (21–23), as well as findings suggesting distress is related to disease severity 
(17,24). Additionally, longitudinal research has highlighted that those who have an improvement 
in the severity of their dystonia were less depressed compared to those whose dystonia had 
worsened (25), suggesting that depression and anxiety may be primary symptoms of dystonia 
with a biological basis. However, other longitudinal research suggests that distress does not 
improve in line with any improvement in the severity of dystonia (26) and that there is no 
relationship between dystonia severity and psychological distress experienced (27). Thus, there 
may be a secondary role for psychological distress, implying a complex spectrum of neurological 
and psychological symptoms (28). 
Theories of dystonia have developed and expanded to include findings related to the 
neurological, motor and psychological features (29), along with insights from neurophysiological 
studies (2). As shown, there is conflicting evidence as to whether depression and anxiety are a 
primary feature of the disease or secondary to the impact of living with a movement disorder 
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(11,30). There is evidence to suggest that it could be a combination of both, with different factors 
interacting to contribute to the aetiology of depression, including a dysregulation of the 
metabolism of dopamine and monoamine, a genetic predisposition and adverse life events (31). 
Therefore, a biopsychosocial approach to understanding an individual’s experience and 
difficulties would be beneficial. In addition, research in Parkinson’s disease, has suggested that 
there may be three possible subtypes of depression in this population: those who would have 
been depressed if they had another chronic condition, those who would have been depressed 
without any condition, and those for whom the depression is related specifically to the 
underlying pathophysiology of the disease (32). This may also be the case in dystonia and could 
explain some of the contradictory findings within the research.  
Despite the underlying mechanisms of anxiety and depression in dystonia remaining 
unclear, both have been shown to reduce the quality of life for those who experience them 
(9,10,33,34), as well as contributing to overall levels of disability (11,13,15,35). Given that the 
research on distress in dystonia has tended to focus on the medical model to date, it would be 
pertinent to give attention to the psychological factors within the biopsychosocial framework of 
understanding (31). This would act as an impetus for future research as well as gaining an 
understanding of psychological factors that may be related to anxiety and depression.  This 
understanding would enable formulation-based interventions to help those who were 
experiencing psychological distress in addition to dystonia. A psychological formulation is a 
collaboratively constructed hypothesis about a person’s difficulties which takes into account a 
range of factors including social circumstances, relationships and life events (including the 
presence of disease) and uses this understanding to plan how to move forward (36). 
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For the purposes of this review the term ‘psychological factors’ is used to describe factors 
that are potentially modifiable through psychological intervention, and is in line with how it has 
been defined in previous comprehensive reviews in other movement disorders (37,38).  
Therefore, this review of the literature aims to examine: 
a) Which psychological factors have been investigated in dystonia? 
b) What is the relationship between these factors and anxiety and depression?  
Method 
The framework adopted for the reporting of this systematic review was the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (39). 
Search strategy 
A systematic search of four databases was conducted: CINAHL, MEDLINE, PsycINFO 
and Web of Science. These databases were chosen following guidance from an academic 
librarian and because they covered both medical and psychological research, thus increasing the 
chances of finding relevant papers on dystonia. These were also similar databases to those used 
in a previous review in dystonia (40), with the addition of Web of Science as it is recommended 
as an optimal database for efficient coverage (41). The final search was performed on November 
25th, 2019. Database thesauruses and Medical Search History (MeSH) terms were searched for 
key words relating to dystonia and anxiety/depression. The search strategies also included free-
text searches to capture any articles that may not be indexed correctly. Full details of the search 
strings are available in table 1-1. Searches were filtered to only include peer-reviewed literature 
in the English language. Once the search had been conducted, duplicates were removed, and the 
remaining papers screened for suitability. 
[Table 1-1 about here] 
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Inclusion criteria 
Papers were deemed suitable if they met the following inclusion criteria: 
• Were quantitative empirical research. 
• Participants were adults (aged >16 years) who had a diagnosis of primary 
dystonia. 
• Included a validated measure of anxiety or depression, or diagnosis via gold 
standard diagnostic interview. 
• Included a psychological factor (e.g. coping styles, personality traits). 
• Reported a relationship between the psychological variable and anxiety or 
depression. 
Studies were included if psychological factors were looked at in relation to anxiety or depression 
even if this was not the primary aim of the study.  The subscales of quality of life measures that 
met this criterion (i.e. those that pertained to social and emotional role functioning) were 
included. The ‘validated’ measures of anxiety and depression had been established within 
research as having reliability and validity. Papers were excluded if dystonia was secondary to 
another neurological condition or as an extrapyramidal effect of medication. 
Data extraction and quality assessment 
Data extraction was performed by the author. Information extracted from each study 
included the sample size, age and sex of participants where stated, design and analysis, the 
country where the study was conducted, the psychological variables examined, and measures 
used to assess depression and anxiety. Information was also extracted to assess the risk of bias 
(study quality).  
PSYCHOLOGICAL CORRELATES OF DISTRESS IN DYSTONIA  1-8 
The quality of selected studies was assessed using the Appraisal tool for Cross-Sectional 
Studies (AXIS tool) (42). This scale is designed for cross-sectional research and consists of 20 
questions that measure aspects of study quality including clear aims and objectives, the 
representativeness of the sample, information regarding non-responders, whether validated 
measures were used, statistical methodology and any conflicts of interest (see appendix 1-1 for 
full list of questions). To score the studies, each question was rated on a binary scale with 1 for 
questions that could be answered ‘yes’ and 0 for questions where the answer was ‘no’ or ‘not 
determined’. There were two exceptions to this; questions 13 and 19 where the phrasing meant 
that an answer of ‘yes’ would suggest a higher risk of bias, so these were reverse scored.  
Following the assessment each study was given a score between 0-20, with higher scores 
representing a lower risk of bias and higher quality of research. A colleague also performed a 
quality assessment of a random sample of eight (50%) of the papers to check for bias, followed 
by a discussion to resolve a few minor discrepancies which were related to the interpretation of a 
couple of the questions. For example, the question ‘Were the results for the analyses described in 
the methods, presented?’ was interpreted by one colleague to mean the analyses should be in the 
methods section. The other colleague gave a score if the analyses were described in the methods 
or results section. Final scores were agreed on by both parties.  
Results 
Study selection 
The initial literature search returned 2148 articles from the databases CINAHL (n=97), 
PsycINFO (n=554), Medline (n=262) and Web of science (n=1235). Duplicates were removed 
leaving 1814 articles for screening. The titles and abstracts of these articles were examined 
according to the inclusion and exclusion criteria leaving 57 articles for a full text examination.  
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The reference lists of these articles were also screened for any further studies, but none were 
identified. Following full text examination, 41 studies were excluded due to not including 
anxiety/depression as correlates (n=21), not using a validated measure (n=2), a relationship 
between anxiety depression and other psychological factors not being examined (n=15) and 
using the same cohort and analysis as another study (n=3). This left 16 studies which were 
eligible for inclusion in this review. A flow diagram of the selection process can be seen in figure 
1-1.  
[Figure 1-1 about here] 
General study characteristics and quality appraisal 
Table 1-2 shows a summary of the studies included in the review. All the studies included 
used a cross-sectional design. Correlational analyses were used in seven papers and five carried 
out multiple regressions. Three papers used between groups analyses and one used a cluster 
analysis. Four of the studies were carried out in the UK (24,43–45), four in Germany 
(27,28,46,47), four in the USA (48–51) and one each in Austria (52), Serbia (53), Italy (54) and 
The Netherlands (55). Focal dystonia was examined in 14 of the studies (27,28,43,44,46–55) 
with the remaining two (24,45) using a mixed sample. Two studies also included patients with 
hemifacial spasm within their participants (24,54), though, as they were a small percentage of a 
large sample, the decision was made to include the findings in this review. 
Recruitment for the studies was primarily via hospitals or clinics (27,28,46,47,49,50,52–
55). Three recruited using an existing epidemiological sample (24,45,51), although two of these 
were from the same epidemiological sample (24,45). One study recruited from a mailing list of 
people previously involved in research (44) and another study used a subgroup of these 
participants (43). One study did not specify from where the sample was recruited (48).   
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The studies included represented a total of 1585 participants, not double counting the 
studies which used the same pool of participants (24,43–45,49,50). For those studies which 
included male and female participants and stated the percentage of each gender (n=13), the 
number of males ranged from 25.4% to 80% with a median of 40.8%. For the studies which 
indicated ages (n=12) these ranged from 17-91 years with mean ages ranging from 40.9-64 years. 
For studies that mentioned disease duration (n = 7) this ranged from 6 months to 56.6 years. For 
those that included mean age of onset (n = 9) this ranged from 34.7 years to 56.3 years. 
 
[Table 1-2 about here] 
Quality appraisal 
Table 1-3 outlines the quality appraisal using the AXIS tool (42). The scores from the 
quality appraisal ranged from 12 to 20 out of a possible 20. The main issues which contributed to 
lower scores were not justifying sample sizes and not addressing non-responders. Sample sizes 
ranged from 18 to 329, with a median of 86. One study justified their sample size with a sample 
size calculation for a power of 0.85 (55). Participant characteristics were described in all of the 
studies and 11 addressed non responders (24,27,28,43–45,47,49–51,55). Response rates were 
stated in six studies and ranged from 68% (44) to 92.4% (27). For the 68% response rate it was 
reported that there were no differences between the responders and non-responders in terms of 
clinical and demographic variables (44). 
Three studies took steps to account for multiple statistical tests. One utilised the 
Bonferroni correction (46) and two adjusted their significance level to p<0.001 (43) and p<0.005 
(45). Other studies that used a high number of statistical tests without taking steps to mitigate 
this were more vulnerable to type 1 error (24,28,44,47,48,50,51,53–55).  
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[Table 1-3 about here] 
Outcome measures 
The majority of the studies looked at both anxiety and depression (27,28,47–51,53–55).  
Five looked at only depression (24,43–45,52) and one at only anxiety (46).   
A number of different measures were used to assess depression and anxiety. The 
following measures were used to assess depression: the Beck’s Depression Inventory (BDI) (56) 
(n=7) (24,43–45,52,54,55), the Beck’s Depression Inventory II (BDI-II) (57) (n=1) (51), the 
Self-Rating Depression Scale (SDS) (58) (n=1) (48), the Patient Health Questionnaire-9 (PHQ-9) 
(59) (n=1) (51), and the Hamilton Depression Rating Scale (HDRS) (60) (n=1) (53). 
Anxiety was examined using the following measures: the State-Trait Anxiety Inventory 
(STAI) (61) (n=2) (48,54), the Hamilton Anxiety Rating Scale (HARS) (62) (n=1) (53), the 
Competitive Trait Anxiety Inventory (CTAI) (63) (n=1) (46), the Social Phobia Scale (SPS) (64) 
(n=1) (27), the Beck Anxiety Inventory (BAI) (65) (n=1) (55) and The Liebowitz 
Social Anxiety Scale (LSAS) (66) (n=1) (51). The following measures looked at both depression 
and anxiety: the Hospital Anxiety and Depression Scale (HADS) (67) (n=3) (49–51) and the 
anxiety and depression subscales of the Symptom Checklist-90 (SCL-90) (68) (n=1) (47).   
Two studies (27,28) assessed  for psychiatric comorbidity (including anxiety and 
depression) using the Structured Clinical Interview for DSM-IV (SCID) (69).  
Prevalence of anxiety and depression in the samples 
Current prevalence of anxiety and/or depression was reported in nine of the studies 
(24,27,43,44,48,50–52,55). The prevalence rates for depression ranged from 2.8% (50) to 53.4% 
(27). The prevalence rates for anxiety ranged from 11% for state anxiety (48) or 13.4 % for 
general anxiety (50) to 50% (27). Hu (50) commented on the particularly low rates of anxiety 
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and depression in their sample compared to the wider literature, suggesting that their participants 
had been living for a long time with SD (mean duration >10years) and were established on 
effective doses of botulinum toxin. In addition, the rates for anxiety in the study conducted by 
Gundel et al.(27) were higher than has been reported in previous research. This may be because 
they modified the social phobia diagnosis in the DSM-IV to allow it to be applied to those with a 
disabling or disfiguring physical condition. Traditionally these participants would not have met 
the criteria for this diagnosis, therefore increasing the prevalence rates in this study.    
Correlates of anxiety and depression 
Body concept 
Body concept (BC) is the conceptual image about one’s own body and was examined in 
five studies in relation to anxiety and depression (24,27,43–45). Four of these (24,43–45) used 
the ‘Body Concept Scale’ developed by Jahanshahi and Marsden (25), where a higher score 
indicates a more negative BC. Two studies also included a measure of ‘disfigurement’ (24,44), a 
single item rating scale designed to assess the degree of self-perceived disfigurement. Jahanshahi 
and Marsden (44) found that BC was significantly correlated with depression in CD with a large 
effect size, with a more negative BC relating to an increase in depressive symptoms. However, 
when entered into a hierarchical multiple regression analysis alongside disfigurement, 
extraversion, neuroticism, and functional disability, BC accounted for less than 1% of the 
variance of depression. They suggested that the contribution of BC was minimal once the effects 
of perceived disfigurement had been accounted for, with disfigurement accounting for 13.5% of 
the variance in depression. Jahanshahi (43) again found that a more negative BC was associated 
with an increase in depressive symptoms in CD (with a large effect size). However, it was not a 
significant predictor in a stepwise multiple regression when included alongside self-depreciation, 
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disability, maladaptive coping, satisfaction with social support, belief in control by powerful 
others and three ratings of clinical severity. Lewis et al. (24) extended these studies to include 
participants with focal, generalised or segmental dystonia. They found that negative BC was still 
associated with an increase in depressive symptoms. In a stepwise multiple regression alongside 
self-esteem, disfigurement and quality of life, BC accounted for 6% and disfigurement accounted 
for 2% of the variance of depression scores. This variance accounted for by BC was maintained 
once the analyses was repeated to exclude participants with CD suggesting that this relationship 
affects those with other types of dystonia. However, disfigurement was no longer a significant 
variable once the analyses was repeated to exclude participants with CD suggesting this concept 
may be more relevant to those with CD than other types of dystonia. Page et al. (45) also 
included participants with varying types of dystonia. They looked at depression as a predictor of 
BC and found that scores on the BDI accounted for 43% of the variance in BC, highlighting the 
potential bidirectional relationship between these two concepts.  
In the Gundel et al. (27) study, participants assessed their body image dissatisfaction on a 
self-rating visual analogue scale (VAS), with higher values indicating greater body image 
dissatisfaction. In their stepwise multiple regression analysis, they found that body image 
dissatisfaction was one of the independent predictors of social phobia when examined alongside 
education, marital status, tsui score (severity of CD), extent of CD, frequency of Botox, pain, 
significant life event in year prior to diagnosis and depressive coping. 
Self-esteem 
Self-esteem was examined in two studies (24,43). In Jahanshahi (43) this was divided 
into self-worth and self-depreciation using the Rosenberg’s self-esteem scale (RSES) (57). Their 
findings showed that the participants who were moderately to severely depressed, as measured 
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using a cut off score of 17 on the BDI, had significantly lower self-worth and significantly higher 
levels of self-depreciation. Both of these measures were also strongly correlated with depression 
with a large effect size. In a stepwise regression analysis alongside disability, degree of head 
control, satisfaction with social support and maladaptive coping; self-depreciation was the 
strongest predictor of depression, accounting for 59% of the variance. A further regression 
analysis with self-depreciation as the outcome variable showed that BC and maladaptive coping 
accounted for 52% and 7% respectively of the variance in self-depreciation.  
Lewis et al. (24) also used the RSES but used an overall score of self-esteem. They found 
that self-esteem was negatively correlated with depression with a medium effect size and, in a 
stepwise regression analysis, accounted for 56% of the depression scores when controlling for 
BC, disfigurement and quality of life. This only dropped slightly to 55% once they repeated the 
analysis to exclude participants with CD. This study also looked to isolate the contributors to 
self-esteem, and again found that BC was the strongest predictor, explaining 38% of the variance 
in self-esteem.  
Coping 
Four studies looked at coping styles in relation to psychological distress (27,43,46,47). 
The ‘Freiburger Fragebogen zur Krankheitsverarbeitung’ (FKV) (58) was used by two of the 
studies as a tool to examine coping strategies in people living with CD (27,47).  Scheidt et al. 
(47) found that higher scores in depressive coping (described as cognitions and emotional 
attitudes towards the disease such as feeling guilty and blaming oneself), active problem 
focussed coping, and wishful thinking (described as denial and escapism into fantasy) were all 
related to increases in anxiety and depression. The effect size of wishful thinking and active 
problem focussed coping was small and the effect size for depressive coping was medium. 
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Gundel et al. (27) found that, in a stepwise regression alongside body image dissatisfaction, 
clinical variables and demographic variables, depressive coping was the main predictor of 
psychiatric comorbidity (including anxiety and depression) and social phobia.  
Ioannou and Altenmueller (46) used the Stress Coping Questionnaire (SVF-78) (59) and 
found that coping strategies of ‘mental perseveration’ (described as being unable to break off 
from thoughts) and ‘self-incrimination’ (described as attributing stress to one’s own mistakes) 
were correlated with the self-doubt concern and somatic anxiety subscales of the CTAI with a 
medium to large effect size in focal hand dystonia.  They also found that the coping strategy of 
‘flight tendency’ (described as using thoughts of escape) was not significantly correlated with the 
subscales of the CTAI.  In Jahanshahi’s (43) study the ‘ways of coping’ checklist (73) was used, 
adapted for chronically ill populations (74). They divided the coping strategies into either 
‘maladaptive coping’  for those that were associated with increased depressive symptoms (wish 
fulfilling fantasy r = 0.48, religious faith r = 0.24), or ‘adaptive coping’  for those associated with 
fewer depressive symptoms (threat minimisation r = -0.46, positive appraisal r = -0.08, cognitive 
restructuring r = -0.18, instrumental coping r = -0.04). When entered into a stepwise multiple 
regression alongside self-depreciation, disability, degree of head control, and satisfaction with 
social support, maladaptive coping explained 1.7% of the variance in depressive symptoms.  
Personality traits 
Personality traits were examined in three studies (28,44,46). Specifically perfectionism 
(46), extraversion (28,44), neuroticism (28,44) and openness (28). Ioannou & Altenmueller (46) 
examined perfectionism in musicians with focal hand dystonia using the Frost Multidimensional 
Perfectionism Scale (FMPS) (62). They found that ‘concern over mistakes’ and ‘doubts about 
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actions’ were both positively correlated with the ‘self-doubt concern’ and ‘somatic anxiety’ 
subscales of the CTAI with medium to large effect sizes.  
Extraversion and neuroticism were examined in two studies (28,44). Jahanshahi & 
Marsden (44) measured these using the Eysenck Personality Questionnaire (76) and Lencer et al. 
(28) used the NEO five factor inventory (NEO-FFI) (64). Jahanshahi & Marsden (44) found that 
depression was positively correlated with neuroticism and negatively correlated with 
extraversion, both having medium effect sizes. They also found that, when entered into a 
stepwise regression alongside functional disability, BC and disfigurement, extraversion 
accounted for 14% and neuroticism accounted for 13% of the variance of depression. Lencer et 
al. (28) looked at the difference between groups of those with primary focal dystonia either 
affected by, or not affected by, a psychiatric disorder as measured using the SCID. They found 
the participants who met the criteria for a diagnosis of major depression or anxiety scored 
significantly higher on scores of neuroticism than those who did not meet the criteria. This 
difference was not observed on scores of extraversion. Those who met the criteria for social 
phobia scored significantly higher on the scale of neuroticism, and significantly lower on the 
scale of extraversion than those without social phobia. They also looked at scores of ‘openness’ 
and found no significant differences between those with anxiety, depression or social phobia and 
those without. Despite the different findings, both studies examining extraversion were similar in 
terms of quality which was rated as good.  
Self-efficacy and locus of control 
Self-efficacy was examined in two studies (49,50) relating to anxiety and depression in 
participants with SD. Both studies used the same sample of participants but different analyses.  
Self-efficacy was measured using the General Self-Efficacy Scale (GSES) (78) alongside a 
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Disease Specific Self-Efficacy in SD Scale (DSSES) which was developed by the authors in the 
first paper and based in part on the GSES (49). In Hu et al. (49) they found that higher levels of 
general self-efficacy (GSE) were significantly correlated with lower levels of anxiety and 
depression with medium effect sizes, and that higher levels of disease specific self-efficacy 
(DSSE) were significantly correlated with lower levels of anxiety and depression with medium 
to large effect sizes. Hu et al. (50) entered these variables into a linear regression model 
alongside demographic variables and measures of clinician and subjective ratings of voice. They 
found that GSE was a significant predictor of anxiety but not depression (p<0.001) and that 
DSSE was a significant predictor of depression but not anxiety (p<0.001). However, the linear 
regression models included both measures of self-efficacy which may have correlated highly 
with each other leading to issues of multicollinearity.  
In the analysis done by Jahanshahi (43) locus of control was examined using the 
Multidimensional Health Locus of Control Scale (MHLOC) (79). This is divided into three 
subscales relating to belief in control by internal, chance and powerful others. Correlation 
analysis showed that a higher level of belief in internal control was significantly correlated with 
lower levels of depression with a small to medium effect size, whereas a higher belief in the 
control of powerful others was significantly correlated with an increase in depression with a 
large effect size.   
Psychosocial Subscales of Quality of Life Measures  
Two studies looked at depression/anxiety in relation to the psychosocial subscales of the 
SF-36 quality of life measure (53,55). In a univariate analysis Smit et al. (55) found that lower 
scores on the domain of ‘social functioning’ were significantly correlated with increased 
depression with a medium effect size, but not anxiety (though this had a small effect size). They 
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also found that lower scores on ‘emotional role limitation’ were significantly correlated with an 
increase in both anxiety and depression in participants with CD, with a medium to large effect 
size.    
Pekmezovic et al. (53) included participants with CD, blepharospasm and writer’s cramp.  
Lower scores in social functioning were significantly correlated with higher levels of depression 
for all groups (large effect sizes) and with anxiety for CD and blepharospasm (medium to large 
effect sizes) but not writer’s cramp despite this still having a medium effect size. Lower scores 
on the emotional role limitation domain were significantly correlated with an increase in anxiety 
and depression for CD and blepharospasm (medium to large effect sizes) but not writer’s cramp 
despite this also having a medium effect size for both anxiety and depression. Out of these two 
studies, Smit et al (55) was of a higher quality.  
Social support 
Only one study considered the role of social support in relation to depression in CD (43) 
which was measured using the Social Support Questionnaire (80). This measure looks at both the 
amount of social support available and the individual’s satisfaction with that support. Correlation 
analyses found that a lower amount of support, and low levels of satisfaction with support were 
significantly correlated with an increase in depressive symptoms with a medium effect size. In a 
stepwise multiple regression, satisfaction with social support accounted for 1.6% of the variance 
in depression scores when entered into the model with self-depreciation, disability, degree of 
head control and maladaptive coping.  
Sexual wellbeing 
Sexual wellbeing was considered in one study looking at CD and blepharospasm (54).  
This was evaluated using the Sexual Functioning Inventory (SFI) (81) which has the subscales of 
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infrequency, non-communication, dissatisfaction, avoidance, non-sensuality, premature 
ejaculation/vaginismus and impotence/anorgasmia. Their analysis showed that a lower level of 
sexual wellbeing (as indicated by a higher overall score on the scale) and high scores of 
infrequency were significantly correlated with an increase in depressive symptoms with a small 
to medium effect size. High scores of sexual infrequency were also significantly correlated with 
an increase in anxiety with a medium effect size.    
Substance Abuse 
One study looked at the role of substance abuse in CD (51). Their analysis found that 
participants who met the criteria for substance abuse as determined by the SCID had a 
significantly higher level of depressive symptoms (as measured by the PHQ-9 and BDI-II) and 
distress (as measured by the HADS total score). As the HADS total score was used it is not clear 
whether this also suggested higher rates of anxiety. Social anxiety specifically as measured by 
the LSAS was not significantly different in those who met the criteria for substance abuse 
compared to those who did not.  
Other psychological concepts 
Other psychological concepts were examined in two of the studies, somatic complaints 
(48,52) interpersonal sensitivity, obsessive compulsiveness and psychoticism (52). Moraru et al. 
(52) used the subscales of the Symptom Checklist (SCL-90) (68) to examine whether there was 
any correlation with depression as measured by the BDI in participants with CD. The sample size 
in this study was small (n=40). The findings suggested that those who were moderately/severely 
depressed (n=5) scored significantly higher on the subscales of somatization, obsessive-
compulsiveness symptoms, interpersonal sensitivity and psychoticism when compared to non-
depressed participants (n=23). When they compared the non-depressed participants with those 
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who scored as mildly depressed (n=12) they found a significant difference in scores for 
obsessive-compulsiveness, hostility and somatisation.  
Cannito (48) also examined somatic complaints in a sample with SD. The measure used 
was a Somatic Complaints Checklist developed by the author. They found that an increase in 
somatic complaints were significantly correlated with an increase in depression and state anxiety, 
both with a large effect size. There was no significant correlation between somatic complaints 
and trait anxiety although there was a medium effect size (r = 0.29), so the lack of statistical 
significance may be due to the study being underpowered to detect this effect (n=18).  Both 
studies examining somatic complaints were of a low quality. 
Discussion 
This review sought to examine which psychological factors have been investigated in 
dystonia and what their relationship was with anxiety and depression. The limited number of 
studies identified (n=16) suggests that there has been little focus on psychological correlates of 
anxiety and depression in dystonia. The most frequently examined factors were BC, coping and 
personality traits followed by self-esteem, psychosocial domains of QoL, self-efficacy and 
somatic complaints. In addition, some of these factors seemed to interact with each other to 
influence the overall scores of depression and anxiety. Other factors were only included in single 
studies including locus of control, social support, sexual wellbeing, substance abuse and 
psychological symptoms as measured by the SCL-90.  
BC was the most examined psychological factor in relation to depression. This is a 
multifaceted concept which incorporates an individual’s feelings and beliefs about their body 
including an evaluation of how it is perceived by others (82). Negative BC has been shown to be 
experienced by people with dystonia and a review found it was related to poorer quality of life 
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outcomes (83). The results here suggest it is also related to depression with a large effect size.  
When examined alongside a variety of other demographic and psychological variables, the 
reliability of BC as a predictor of depression varied when perceived disfigurement was included 
as another variable. The results were not consistent between studies. Lewis et al. (24) suggested a 
larger role of BC, and Jahanshahi and Marsden (44) found that disfigurement accounted for the 
majority of the variance in depression. In addition, Lewis et al. (24) found that disfigurement was 
no longer a significant predictor when those with CD were removed from the analysis. This 
suggests there is some complexity and overlap between these two constructs which may warrant 
further investigation, as well as a difference between different types of dystonia. BC was found 
to be a reliable predictor of social phobia (27), although this study did not include a measure of 
perceived disfigurement. The findings also support a relationship between BC and self-
depreciation which adds another layer of complexity into these potential relationships. 
Sociologists generally consider the body to be central to our self-identity and the image we have 
of ourselves (84). Research into body image has shown that there is a strong relationship 
between levels of self-depreciation and an individual’s view of their own body image (85). Body 
image has also been looked at in relation to multiple sclerosis (86) showing evidence for the 
impact this has on psychological outcomes such as depression and self-esteem. Both self-esteem 
and self-depreciation were correlated with depression with large effect sizes in this review. In 
addition, one study looked specifically at whether depression predicted BC (45), highlighting the 
potential bi-directional relationship between these two concepts. Further longitudinal research 
could help identify in more detail how BC, disfigurement, and self-esteem may be interrelated 
and impact on each other as well as on the experience of psychological distress.  
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After BC, coping strategies were the next most examined concept. Coping is thought to 
mediate the relationship between stress, including that related to a chronic health condition, and 
psychological outcomes such as anxiety and depression (87,88). Coping strategies were found to 
correlate with anxiety and depression with small to large effect sizes and were independent 
predictors when entered into regression models. Coping styles were generally divided into 
‘adaptive’ and ‘maladaptive’. Maladaptive coping styles included depressive coping, wishful 
thinking, mental perseveration, self-incrimination, flight tendency and religious faith. Adaptive 
coping styles included ‘active problem focussed’ coping, threat minimisation, positive appraisal, 
cognitive restructuring and instrumental coping. The results from the review regarding coping 
were largely in keeping with the wider literature that suggests maladaptive coping styles can lead 
to increased levels of distress (89–91). One of the exceptions to this finding was that ‘active 
problem focussed’ coping, which would be classified as a more ‘adaptive’ strategy, was related to 
higher levels of anxiety in one of the studies, albeit with a small effect size (47). This may be 
because the impact of coping strategies can also be dependent on the specific context of the 
stressful situation (92,93). There is evidence that coping styles are not necessarily utilised in 
isolation (94). Therefore, participants may have used maladaptive coping strategies alongside the 
adaptive coping strategies, or utilised ‘active problem focussed’ coping in relation to a specific 
stressor. These findings suggest the relationship between distress and coping is complex and that 
it might be useful to consider the context in which a coping style is used before deciding if it is 
adaptive or not. In addition, the cross-sectional design of the study also limits how much can be 
inferred from the findings. For example, it may be that the anxiety had prompted the use of the 
active problem solving, rather than being a result of this, or indeed both the increase in anxiety 
and the increase in problem solving could be due to other underlying factors. Furthermore, 
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categorising coping in ways such as ‘maladaptive’ and ‘adaptive’, although useful for broader 
investigation, can undermine the potential relationships between strategies and the complexity of 
managing stress relating to chronic illness (92,95). Nonetheless there is some evidence to support 
the role that coping plays in psychological distress and attention should be given to this in future 
research.  
Personality traits (neuroticism, extraversion and perfectionism) were looked at across a 
range of dystonia types and found to be related to anxiety and depression with a medium effect 
size. They were reliable predictors when examined alongside a variety of other demographic and 
psychological variables. Personality is thought to affect coping styles and emotional responses to 
the experience of having a chronic illness (96) and have been examined in the broader general 
literature on psychological distress and wellbeing (97,98).  
Neuroticism has also been linked to individuals experiencing negative emotional 
responses in threatening situations (99) which could be related to the stress of living with a 
chronic condition. There were differences between two studies on whether extraversion was 
related to lower levels of depression (28,44) despite both studies being of a similar quality, but 
the null finding of Lencer et al. (28) may have been due to the small sample size (there were only 
five participants in the ‘depressed’ group) or the fact that Jahanshahi and Marsden (44) used the 
BDI whereas Lencer et al. (28) used the SCID. Perfectionism has been shown to lead to lower 
levels of wellbeing and has also been linked to higher levels of neuroticism (100) suggesting 
there may be interplay between different personality traits. In addition, the concept of 
extraversion has been shown to have different facets which may not have been captured in the 
measures used, and which have different relationships with depression (101).  
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Higher levels of self-efficacy, as measured by both a general and a disease specific scale, 
was found to be related to lower levels of distress with medium to large effect sizes. They were 
also reliable predictors of anxiety (GSE) and depression (DSSE) (49,50). Self-efficacy is an 
individuals belief that they are able to achieve a specific goal or task and has been shown to have 
a strong relationship with health behaviours (102). It has also been associated with psychological 
outcomes in other movement disorders such as multiple sclerosis (103). The findings in this 
review also considered the relationship between locus of control (the belief someone has in how 
much control they, or external forces, have over a situation) and psychological distress. Other 
areas of health research have suggested that high levels of a belief in chance, or in powerful 
others, can lead to increased levels of distress and lower quality of life (104,105) and these 
findings were echoed in this review. However, an external locus of control may also be seen as 
being more realistic and adaptive for conditions which are considered chronic (106). Locus of 
control has been shown to change over the course of an illness (107) which suggests that 
duration of disease may also be a relevant factor when examining this in the research. However, 
in the reviewed studies the disease duration of participants was too varied to draw any 
conclusions as to possible interactions between this and locus of control.  
Psychosocial subscales of a quality life measure, namely ‘emotional role limitation’ and 
‘social functioning’, were found to be related to anxiety and depression across different types of 
dystonia with medium to large effect sizes. The SF-36 is a commonly used measure of quality of 
life and has been frequently used in dystonia (108). Concerns have been raised about its use with 
other neurological disorders (109–111) and an analysis of the measure in the context of dystonia 
found that the ‘role emotional’ scale had large floor and ceiling effects (112). This suggests this 
subscale may underestimate any clinical change and the results should be interpreted with 
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caution. However, the ‘social functioning’ subscale was found to be reliable and can be 
interpreted with more confidence (112). Although the two studies showed differing results in 
relation to the link between anxiety and social functioning, the study by Smit et al. (55) showed 
findings that approached significance and that had a small effect size. In addition, this study was 
rated as a higher quality than Pekmezovic et al. (53) which may add more strength to their 
findings.   
The findings from Moraru et al. (52) suggested that somatization, obsessive-compulsive, 
interpersonal sensitivity, hostility and psychoticism all played a role in depression, and similar 
findings have been observed in Parkinson’s disease (113). The findings that somatic complaints 
were correlated with anxiety and depression should be interpreted with caution as the scales used 
to examine anxiety and depression also include questions regarding somatic complaints. In 
research looking at the role of somatization in disability, the unique contributing effect of 
somatization reduced when anxiety and depression were added to the model (114) posing a 
challenge when formulating the relationships between these constructs.   
In addition to the single studies examining locus of control and the SCL-90, sexual 
wellbeing, social support and substance abuse were also only investigated once. Aspects of 
sexual wellbeing were correlated with anxiety and depression with medium effect sizes. Social 
support was correlated with depression with a medium effect size and was also an independent 
predictor in a regression model. Substance abuse was found to be related to higher levels of 
depression and distress. As these were only looked at in singular studies it can be hard to draw 
conclusions beyond highlighting the need for conducting more research within this area.   
Clinical Implications 
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The range of psychological variables looked at in relation to anxiety and depression 
highlights the need for individual and holistic psychological formulations for people with 
dystonia who are also struggling with psychological distress. However, evidence for effective 
behavioural interventions in dystonia is limited (40). Treatment options tend to be based on 
recommendations developed for non-dystonic populations (35) and the recommended treatment 
for depression, anxiety and social phobia is cognitive behavioural therapy (CBT) (31,40,115). 
One study has examined the use of CBT and mindfulness in dystonia (115) and their findings 
suggested that a three-day residential programme utilising these approaches improved wellbeing 
and reduced distress. However, they caution that inferences from their data are limited due to the 
low number of participants (n=9). Qualitative data from the study also suggested that 
mindfulness was used as a coping style at follow up. Consideration should be given for the utility 
of CBT in relation to social phobia as people living with dystonia often experience scrutiny and 
negative responses such as stigma from others (116,117) so an approach that focusses on 
challenging ‘incorrect beliefs’, including performing behavioural experiments, may be 
counterproductive. An approach such as Acceptance and Commitment Therapy (ACT) may be 
more beneficial as the focus is on developing valued behaviours whilst accepting, rather than 
trying to change, any thoughts and feelings (118). ACT has shown promise as an intervention in 
long term health conditions and muscle disorders (119).   
Given the role of body image and self-esteem in depression, interventions that focus on 
feelings of embarrassment and shame could be considered for this population. One such 
approach is to develop self-compassion, a gentle and kind way of relating to oneself during 
suffering as opposed to self-criticism (120), which can be developed using a Compassion 
Focussed Therapy approach (121). Self-compassion has been shown to decrease negative affect 
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in a study looking at participants with visible skin conditions (122). There is also evidence that it  
reduces body related distress and increases body appreciation in participants with breast cancer 
(123). Self-compassion has been associated with an increase in adaptive coping and decrease in 
maladaptive coping strategies in the context of chronic illness (124) suggesting that this may be a 
viable approach for these factors in those with dystonia.  
Limitations 
The BDI was the most commonly used measure of depression in the studies reviewed, 
however only one study engaged with the measure of the BDI in a way that considered the 
overlap in symptomology of dystonia (24). Scores on some of the measures may be artificially 
inflated due to their reliance on symptoms such as fatigue and sleep disruption which may be 
more related to the symptomology of dystonia rather than psychological distress (19). In 
addition, many of the tools used were screening rather than diagnostic which tend to focus on the 
two weeks prior to completion (125). This also makes it more difficult to draw comparisons 
between those studies that used screening measures and those which used the SCID which is a 
diagnostic tool. In addition, the wide variety of measures used outside of the BDI made 
comparisons and assimilation of the research difficult.  
Another limitation was that the studies were all cross-sectional in design so causation 
cannot be inferred, and relationships may be bi-directional, as was shown in the relationship 
between body image and depression. The majority  of the studies were also vulnerable to type 1 
error due to the large number of statistical tests performed on the data, with only three 
accounting for this by either adjusting the significance level or utilising the Bonferroni 
correction. Therefore, caution should be applied when interpreting these results. 
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Furthermore, this review contained studies which examined a range of different types of 
dystonia. Whilst this is useful for an overall picture, the experiences of distress and 
psychological variables may differ depending on type and location of the condition. 
Future research 
This review highlighted that research on the psychological factors involved in anxiety 
and depression in those living with dystonia is limited. Research carried out with this population 
should remain critical of the measures used and take steps to ensure validity with this population.  
One option to consider might be the Depression Anxiety Stress Scale -21 (DASS-21) (126,127) 
which, although not used specifically with dystonia, has been used with other neurological 
conditions which present with a motor element (128,129). In addition, looking more closely at 
relationships between psychological factors and their effect on anxiety and depression utilising 
more complex statistical models and a longitudinal design will further advance understanding of 
the mechanisms involved in the development and maintenance of distress. An example of this 
would be a model that seeks to examine the relationship between BC, perceived disfigurement, 
self-depreciation and depression in those with cervical dystonia.  
Social support is another area which warrants further research. It was only examined in 
one study within this review, however other reviews looking at psychological correlates of 
anxiety, depression and adjustment in both Parkinson’s disease and multiple sclerosis identified 
social support and interactions as being related to levels of distress and adjustment (37,38). 
Social context and how it might impact on how one relates to oneself would also be a useful 
focus of future research, particularly given the increased amounts of stigma experienced by this 
population (116). 
Conclusion 
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Drawing on a biopsychosocial understanding, this review aimed to identify research that 
had been conducted on psychological variables in relation to anxiety and depression and explore 
the strength of these relationships. A search of the literature revealed limited research had been 
done in this area, but included factors relating to distress such as coping styles, BC, self-esteem 
and personality traits, indicating a role for psychological variables and highlighting the need for 
more comprehensive research in this area. This also has clinical implications for the assessment 
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Table 1-1 
Database search strategy 
Table 1-1 Database search strategy 
CINAHL [97 hits] 
Focus 1 Focus 2  
Dystonia 
• MH "Dystonia" 
• MH "Dystonic Disorders" 
• MH "Dystonia Musculorum 
Deformans" 
• MH "Focal Hand Dystonia" 
• MH "Meige Syndrome" 
• MH "Torticollis" 
• Free text “Dystonia musculorum 
deformans OR dystonic 
disorders OR generali?ed 
dystonia OR dystonia* OR 
torticollis* OR cervical dystonia 
OR spasmodic dysphonia* OR 
musician* cramp OR writer* 




• MH "Depression" 
• MH "Affective Disorders" 
• MH "Anxiety" 
• Free text “anxiety or 
depression or psychiatric 
disorders or mental health or 
distress or stress or mood or 
wellbeing” 
 
MEDLINE [262 hits] 
Focus 1 Focus 2  
Dystonia 
• MH "Dystonia" 
• MH "Dystonic Disorders" 
• MH "Dystonia Musculorum 
Deformans" 
• MH "Meige Syndrome" 
• Free text “Dystonia musculorum 
deformans OR dystonic 
disorders OR generali?ed 
dystonia OR dystonia* OR 
torticollis* OR cervical dystonia 
OR spasmodic dysphonia* OR 
musician* cramp OR writer* 
Anxiety/ Depression 
• MH "Depression" 
• MH "Anxiety Disorders" 
• MH "Anxiety" 
• MH “phobia, social” 
• Free text “anxiety OR 
depression OR psychiatric 
disorders OR mental health 
OR distress OR stress OR 
mood OR wellbeing” 
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cramp OR blepharospasm* OR 
meige* syndrome” 
 
PsycINFO [554 hits] 
Focus 1 Focus 2  
Dystonia 
• DE "Torticollis"  
• DE "Tremor"  
• DE "Muscular Disorders"  
• DE "Muscle Spasms" 
• Free text “Dystonia musculorum 
deformans OR dystonic 
disorders OR generali?ed 
dystonia OR dystonia* OR 
torticollis* OR cervical dystonia 
OR spasmodic dysphonia* OR 
musician* cramp OR writer* 




• DE "Anxiety Disorders"  
• DE "Death Anxiety"  
• DE "Generalized Anxiety 
Disorder"  
• DE "Obsessive Compulsive 
Disorder"  
• DE "Panic Attack"  
• DE "Panic Disorder"  
• DE "Phobias"  
• DE "Separation Anxiety 
Disorder"  
• DE "Trichotillomania" 
• DE "Anxiety" 
• DE "Major Depression"  
• DE "Anaclitic Depression"  
• DE "Dysthymic Disorder"  
• DE "Endogenous 
Depression" 
• DE "Late Life Depression"  
• DE "Reactive Depression"  
• DE "Recurrent Depression"  
• DE "Treatment Resistant 
Depression" 
• DE "Affective Disorders"  
• DE "Depression (Emotion)" 
• Free text “anxiety OR 
depression OR psychiatric 
disorders OR mental health 
OR distress OR stress OR 
mood OR wellbeing” 
 
 
Web of Science [1876 hits] 
Focus 1 Focus 2  
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Dystonia 
• Free text “Dystonia musculorum 
deformans OR dystonic 
disorders OR generali?ed 
dystonia OR dystonia* OR 
torticollis* OR cervical dystonia 
OR spasmodic dysphonia* OR 
musician* cramp OR writer* 




• Free text “anxiety OR 
depression OR psychiatric 
disorders OR mental health 
OR distress OR stress OR 
mood OR wellbeing” 
 
 
Note: MH = MesH; DE = Descriptors.  Searches were conducted on titles and abstracts.  All 
terms for within focus were combined with OR.  Focus 1 and 2 were combined with AND. 
  
Running head: PSYCHOLOGICAL CORRELATES OF DISTRESS IN DYSTONIA 1-48 
 
Table 1-2 
Characteristics of included studies 
Table 1-2 Characteristics of included studies 
Study/ 
country 



















(control group = 18 
healthy controls) 




STAI; SDS Somatic complaints were 
correlated with depression 
(r=.535; p<.05) and state 
anxiety (r= .563; p<.05), but 
not trait anxiety (r=.292). 























Depressive coping (p<0.01; 
odds ratio=10.8, 95% CI 3.0-
40.1) was the main predictor 
of current psychiatric 
comorbidity.  Body image 
dissatisfaction was a 
predictor of social phobia 
(p=0.05; odds ratio=2.4, 95% 
CI 1.0-6.3). 









Self-efficacy HADS High self-efficacy was 
negatively correlated with 
anxiety (r = -0.42; p<0.001) 
and depression (r=0.42; 
p<0.001) Disease specific 
self-efficacy was negatively 
correlated with anxiety (r = -
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0.43; p<0.001) and 
depression (r = -0.57; 
p<0.001). 

















HADS In a regression model A 
DSSE was a significant 
predictor of depression 
(p<0.001) and GSES was a 
significant predictor of 
anxiety (p<0.01) 




35 (80%, 45.5) Focal Dystonia 
in Musicians 










All aspects of perfectionism 
and coping examined apart 
from ‘flight tendency’, 
correlated with 2 subscales of 
CTAI (self-doubt concern 
and somatic anxiety) (r= .7 
























BDI Maladaptive coping 
positively correlated with 
depression (r= 0.41; p<0.001) 
and adaptive coping was 
negatively correlated with 
depression (r= -0.27; 
p<0.05). Other correlations of 
depression significant to 
p<0.001were self-
depreciation (r= 0.77)), self-
worth (r= -0.71), 
disfigurement (r= 0.5), social 
support amount (r = -0.29) 
and satisfaction (r = -0.36), 
body concept (r = 0.72) and 
belief in control of powerful 
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others (r = 0.54).  A 
significance level of 
(p<0.001) was chosen to 
account for the number of 
correlations.  Stepwise 
multiple regression showed 
variance in depression 
explained by self-
depreciation (59%), 
Satisfaction with social 
support (1.6%) and 




















BDI Disfigurement rating (r =  
0.39), extraversion (r = -
0.42), neuroticism (r = 0.54), 
and body concept (r = 0.70) 
were correlated with 
depression (p<0.05). In the 
regression model variance in 
depression scores was 
explained by extraversion 
(13.6%), disfigurement 
(13.5%) neuroticism (13%) 
and body concept (0.04%) 
when included with objective 
clinical measures.  























significantly higher in those 
with anxiety (p<0.001), 
depression (p<0.01), panic 
disorder (p<0.001) and social 
phobia (p<0.001); openness 
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compared those 
who are not 
affected) 
was significantly higher in 
those with panic disorder 
(p<0.05); Extraversion was 
significantly higher in those 
with social phobia (p<0.05). 













BDI Self-esteem (r = -0.55; 
p<0.001), body concept (r = 
0.16; p<0.001) and 
disfigurement (r = 0.15) were 
predictors of depression 
explaining 56%, 6% and 2% 












analyses (those who 
met criteria for 
substance abuse 
compared with 






Those who met the criteria 
for substance abuse scored 
higher on the PHQ-9 
(p<0.05), BDI-II (P=0.005) 
and HADS (p<0.005) 
however there were no 
differences between the 



















BDI Somatization, interpersonal 
sensitivity, obsessive 
compulsive and psychoticism 
scales of the SCL-90 were 
significantly different 
between patients with 
severe/moderate depression 
and non-depressed patients. 
(p<0.05) 
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same pool of 
participants as 











BDI BDI predicted body concept 
in stepwise multiple 
regression (r = 0.66; 
p<0.001) explaining 43% of 
the variance in body concept 
score.  
Pekmezovic 

















between depression and 
social functioning across all 
groups (r = -0.621; p<0.001), 
and anxiety and social 
function for the torticollis (r 
= -0.525; p<0.001) and 
blepharospasm (r = -0.351; 
p<0.05) groups, but not 
writer’s cramp (r = -0.386; 
p=0.386).  Significant 
correlations between both 
depression and anxiety and 
role functioning (emotional) 
for the torticollis (r = -0.476; 
r = -0.489; p<0.001)and 
blepharospasm (r = -0.603; 
p<0.001; r = -0.466; p<0.05) 
groups, but not writer’s 
cramp (r = -0.433; p=0.433; r 
= -0.446; p=0.446).  All 
groups showed significant 
correlations between 
depression/anxiety and the 
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mental health subscale (r= -


















BDI, STAI Depression was correlated 
with the total score on the 
SFI (r = 0.238, p=0.024) and 
the infrequency subscale (r = 
0.287, p = 0.006).  The STAI-
X1 correlated with the 
infrequency subscale (r = 
0.306, p = 0.003) as did the 


















Depression and anxiety were 
both significantly correlated 
with depressive coping 
(depression r = 0.68; anxiety 
r = 0.59; p<0.001), active 
problem focussed coping 
(depression  r = 0.13; p<0.05; 
anxiety  r = 0.16; p<0.01) and 
wishful thinking (depression 
r = 0.34; anxiety r = 0.20; 
p<0.001).  











QoL measure  
BDI, BAI Depression was correlated 
with social functioning (r = -
0.65; p<0.01), role limitation 
(emotional) (r = -0.61; 
p<0.01) and mental health (r 
= -0.71; p<0.01).  Anxiety 
was not significantly 
correlated with social 
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functioning (r = -0.25; p<0.2) 
but was correlated with role 
limitation (emotional) (r = -
0.45; p<0.01) and mental 
health (r = -0.65; p<0.01). 
NOTE: BAI (Beck Anxiety Inventory); BDI (Beck Depression Inventory); CTAI (Competitive Trait Anxiety Inventory); HADS (Hospital 
Anxiety and Depression Scale); HARS ( Hamilton Anxiety Rating Scale); HDRS (Hamilton Depression Rating Scale); LSAS (Liebowitz Social 
Anxiety Scale); PHQ-9 (Patient Health Questionnaire-9); (SCL-90 (Symptom Check List – 90); SDS (Self Rating of Depression Scale); SF-36 
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Table 1-3 
Quality appraisal 
Table 1-3 Quality appraisal 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Total 
Cannito, 
1991 
1 1 0 1 0 0 0 1 1 1 1 1 0 0 1 1 1 0 1 0 12 
Gundel et 
al 2001 
1 1 0 1 1 1 1 1 1 1 0 0 1 1 0 0 1 1 1 1 15 
Hu et al 
2013 
1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 18 
Hu et al 
2018 






1 1 0 1 1 1 0 1 1 1 1 1 0 0 1 0 1 1 1 1 15 
Jahansha
hi (1991) 
1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 17 
Jahansha
hi & 
1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 17 





1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 0 16 
Lewis et 
al (2008) 




1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 18 
Moraru et 
al (2002) 
1 1 0 1 1 1 0 1 1 1 1 1 0 0 1 0 1 0 0 0 12 
Page et al 
(2007) 
1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 0 0 15 
Pekmezo
vic et al 
(2009) 




1 1 0 1 1 0 0 1 1 1 1 1 0 0 1 1 1 0 1 1 14 
Scheidt et 
al (1996)1 
1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 0 0 0 14 
 
1 This paper was a single on in a series describing a multicentre study so was examined alongside the first paper of the series which outlined the participants and 
methods..  
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Smit et al 
(2016) 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 
Note: The questions refer to the following sections of studies: 1= introduction; 2-11= method; 12-16 = results; 17-18 = discussion; 19-20 = other.  
Full questions available in appendix 1.  























• Not used validated 
measure (n=2)




























Figure 1-1: Study search flow chart 
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Appendix 1-1 




1. Were the aims/objectives of the study clear? 
Methods 
2. Was the study design appropriate for the stated aim(s)? 
3. Was the sample size justified? 
4. Was the target/reference population clearly defined? (Is it clear who the research was about?) 
5. Was the sample frame taken from an appropriate population base so that it closely represented the 
target/reference population under investigation? 
6. Was the selection process likely to select subjects/participants that were representative of the 
target/reference population under investigation? 
7. Were measures undertaken to address and categorise non-responders? 
8. Were the risk factor and outcome variables measured appropriate to the aims of the study? 
9. Were the risk factor and outcome variables measured correctly using instruments/ measurements 
that had been trialled, piloted or published previously? 
10. Is it clear what was used to determined statistical significance and/or precision estimates? (e.g., p 
values, CIs) 
11. Were the methods (including statistical methods) sufficiently described to enable them to be 
repeated? 
Results 
12. Were the basic data adequately described? 
13. Does the response rate raise concerns about non-response bias? 
14. If appropriate, was information about non-responders described? 
15. Were the results internally consistent? 
16. Were the results for the analyses described in the methods, presented? 
Discussion 
17. Were the authors’ discussions and conclusions justified by the results? 
18. Were the limitations of the study discussed? 
Other 
19. were there any funding sources of conflicts of interest that may affect the authors’ interpretation of 
the results? 
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Appendix 1-2 
Author guidelines for Psychology and Health 
 
 Instructions for authors 
COVID-19 impact on peer review  
As a result of the significant disruption that is being caused by the COVID-19 pandemic we 
understand that many authors and peer reviewers will be making adjustments to their 
professional and personal lives. As a result they may have difficulty in meeting the timelines 
associated with our peer review process. Please let the journal editorial office know if you need 
additional time. Our systems will continue to remind you of the original timelines but we intend 
to be flexible. 
Thank you for choosing to submit your paper to us. These instructions will ensure we 
have everything required so your paper can move through peer review, production and 
publication smoothly. Please take the time to read and follow them as closely as possible, as 
doing so will ensure your paper matches the journal’s requirements.  
 
For general guidance on every stage of the publication process, please visit our Author Services 
website.  
 
For editing support, including translation and language polishing, explore our Editing Services 
website 
  
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer review 
manuscript submissions. Please read the guide for ScholarOne authors before making a 
submission. Complete guidelines for preparing and submitting your manuscript to this journal 
are provided below.  
 
  
This title utilises format-free submission. Authors may submit their paper in any 
scholarly format or layout. References can be in any style or format, so long as a consistent 
scholarly citation format is applied. For more detail see  the format-free submission section 
below . 
Contents 
• About the Journal 
• Open Access 
• Peer Review and Ethics 
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o Preparing Your Paper 
o Structure 
o Word Limits 
o Style Guidelines 
o Formatting and Templates 
o References 
o Editing Services 
o Checklist 
• Using Third-Party Material 
• Disclosure Statement 
• Clinical Trials Registry 
o Complying With Ethics of Experimentation 
o Consent 
o Health and Safety 
• Submitting Your Paper 
• Data Sharing Policy 
• Publication Charges 
• Copyright Options 
• Complying with Funding Agencies 
• My Authored Works 
• Reprints 
About the Journal 
Psychology & Health is an international, peer-reviewed journal publishing high-quality, 
original research. Please see the journal's Aims & Scope for information about its focus and peer-
review policy. 
Please note that this journal only publishes manuscripts in English. 
Psychology & Health accepts the following types of article: Article, Editorial, 
Commentary, Registered Reports. 
Authors are asked to adhere to the guidelines provided and note that reporting 
requirements can vary by study design. 
Original Research Articles include reports of Randomized Controlled Trials (RCTs), 
observational studies, qualitative research studies, and other investigations. All submissions must 
follow the appropriate reporting guidelines and instructions for reporting statistics. 
Reviews are systematic reviews and meta-analyses that are thorough, critical assessments 
of the literature and data sources pertaining to topics within the scope of Psychology and Health. 
Per PRISMA guidelines, systematic reviews and meta-analyses must be identified as such in the 
article title. 
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Commentaries are scholarly but not exhaustive essays of any current issue or controversy 
that fits the scope and aims of Psychology and Health. They should be broadly informative, and 
encourage new thinking or important topics relevant to the readership. 
Registered Reports differ from conventional empirical articles by performing part of the 
review process before the researchers collect and analyse data. Unlike more conventional process 
where a full report of empirical research is submitted for peer review, RRs can be considered as 
proposals for empirical research, which are evaluated on their merit prior to the data being 
collected. For information on how to prepare Registered Reports (RR) submissions please see 
here (https://www.tandf.co.uk//journals/authors/registered-report-guidelines.pdf). 
Authors who are interested in submitting papers that do not fit into these categories are 
advised to contact the editors who would be very happy to discuss the potential submission. 
Editors will not enter into correspondence about manuscripts not accepted for 
publication, and their decision is final. Submission of a manuscript is understood to indicate that 
the authors have complied with all policies as delineated in this guide. 
Open Access 
You have the option to publish open access in this journal via our Open Select publishing 
program. Publishing open access means that your article will be free to access online 
immediately on publication, increasing the visibility, readership and impact of your research. 
Articles published Open Select with Taylor & Francis typically receive 32% more citations* and 
over 6 times as many downloads** compared to those that are not published Open Select. 
Your research funder or your institution may require you to publish your article open 
access. Visit our Author Services website to find out more about open access policies and how 
you can comply with these. 
You will be asked to pay an article publishing charge (APC) to make your article open 
access and this cost can often be covered by your institution or funder. Use our APC finder to 
view the APC for this journal. 
Please visit our Author Services website or contact openaccess@tandf.co.uk if you would 
like more information about our Open Select Program. 
*Citations received up to Jan 31st 2020 for articles published in 2015-2019 in journals 
listed in Web of Science®.  
**Usage in 2017-2019 for articles published in 2015-2019. 
Peer Review and Ethics 
Taylor & Francis is committed to peer-review integrity and upholding the highest 
standards of review. Once your paper has been assessed for suitability by the editor, it will then 
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be single blind peer reviewed by independent, anonymous expert referees. Find out more 
about what to expect during peer review and read our guidance on publishing ethics. 
Preparing Your Paper 
All authors submitting to medicine, biomedicine, health sciences, allied and public health 
journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals, prepared by the International Committee of Medical Journal Editors (ICMJE). 
Structure 
Your paper should be compiled in the following order: title page; abstract; keywords; 
main text introduction, materials and methods, results, discussion; acknowledgments; declaration 
of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on 
individual pages); figures; figure captions (as a list). 
Word Limits 
Please include a word count for your paper. 
A typical paper for this journal should be no more than 30 pages, inclusive of the abstract, 
tables, references, figure captions, endnotes. 
Format-Free Submission 
Authors may submit their paper in any scholarly format or layout. Manuscripts may be 
supplied as single or multiple files. These can be Word, rich text format (rtf), open document 
format (odt), or PDF files. Figures and tables can be placed within the text or submitted as 
separate documents. Figures should be of sufficient resolution to enable refereeing. 
• There are no strict formatting requirements, but all manuscripts must contain the essential 
elements needed to evaluate a manuscript: abstract, author affiliation, figures, tables, funder 
information, and references. Further details may be requested upon acceptance. 
• References can be in any style or format, so long as a consistent scholarly citation format is 
applied. Author name(s), journal or book title, article or chapter title, year of publication, volume 
and issue (where appropriate) and page numbers are essential. All bibliographic entries must 
contain a corresponding in-text citation. The addition of DOI (Digital Object Identifier) numbers 
is recommended but not essential. 
• The journal reference style will be applied to the paper post-acceptance by Taylor & Francis. 
• Spelling can be US or UK English so long as usage is consistent. 
Note that, regardless of the file format of the original submission, an editable version of 
the article must be supplied at the revision stage. 
Taylor & Francis Editing Services 
PSYCHOLOGICAL CORRELATES OF DISTRESS IN DYSTONIA  1-64 
To help you improve your manuscript and prepare it for submission, Taylor & Francis 
provides a range of editing services. Choose from options such as English Language Editing, 
which will ensure that your article is free of spelling and grammar errors, Translation, and 
Artwork Preparation. For more information, including pricing, visit this website. 
Checklist: What to Include  
 
Cover Letter 
The cover letter should describe how the paper fits within the scope of Psychology and 
Health and confirm that it has not been published and is not currently under review elsewhere. 
If the report is based on data from a larger study (e.g., a secondary analysis), please 
include this in your cover letter and reference all publications from the data-set. The cover letter 
should further clarify the novel or value-added scientific contribution of the submitted paper 
relative to previously published papers from the same dataset. 
1. Author details. Please ensure everyone meeting the International Committee of Medical Journal 
Editors (ICMJE) requirements for authorship is included as an author of your paper. All authors 
of a manuscript should include their full name and affiliation on the cover page of the 
manuscript. Where available, please also include ORCiDs and social media handles (Facebook, 
Twitter or LinkedIn). One author will need to be identified as the corresponding author, with 
their email address normally displayed in the article PDF (depending on the journal) and the 
online article. Authors’ affiliations are the affiliations where the research was conducted. If any 
of the named co-authors moves affiliation during the peer-review process, the new affiliation can 
be given as a footnote. Please note that no changes to affiliation can be made after your paper is 
accepted. Read more on authorship. 
2. Should contain a structured abstract of 200 words. Use the following categories: Objective, 
Design, Main Outcome Measures, Results, Conclusion 
3. You can opt to include a video abstract with your article. Find out how these can help your work 
reach a wider audience, and what to think about when filming. 
4. Read making your article more discoverable, including information on choosing a title and 
search engine optimization. 
5. Funding details. Please supply all details required by your funding and grant-awarding bodies as 
follows:  
For single agency grants  
This work was supported by the [Funding Agency] under Grant [number xxxx].  
For multiple agency grants  
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding 
Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx]. 
6. Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen 
from the direct applications of your research. Further guidance on what is a conflict of interest 
and how to disclose it. 
7. Data availability statement. If there is a data set associated with the paper, please provide 
information about where the data supporting the results or analyses presented in the paper can be 
PSYCHOLOGICAL CORRELATES OF DISTRESS IN DYSTONIA  1-65 
found. Where applicable, this should include the hyperlink, DOI or other persistent identifier 
associated with the data set(s). Templates are also available to support authors. 
8. Data deposition. If you choose to share or make the data underlying the study open, please 
deposit your data in a recognized data repository prior to or at the time of submission. You will 
be asked to provide the DOI, pre-reserved DOI, or other persistent identifier for the data set. 
9. Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file 
or anything which supports (and is pertinent to) your paper. We publish supplemental material 
online via Figshare. Find out more about supplemental material and how to submit it with your 
article. 
10. Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi 
for colour, at the correct size). Figures should be supplied in one of our preferred file formats: 
EPS, PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that 
have been drawn in Word. For information relating to other file types, please consult 
our Submission of electronic artwork document. 
11. Tables. Tables should present new information rather than duplicating what is in the text. 
Readers should be able to interpret the table without reference to the text. Please supply editable 
files. 
12. Equations. If you are submitting your manuscript as a Word document, please ensure that 
equations are editable. More information about mathematical symbols and equations. 
13. Units. Please use SI units (non-italicized). 
14. Reporting Checklists. Reporting checklists are required to be uploaded for RCTs, systematic 
reviews/meta-analyses, observational trials, qualitative studies, and evaluations with non-
randomized designs.  
15. Preprint Policy. The journal will consider for review articles previously available as preprints. 
Authors may also post the submitted version of a manuscript to a preprint server at any time. 
Authors are requested to update any pre-publication versions with a link to the final published 
article.  
 
Using Third-Party Material in your Paper 
You must obtain the necessary permission to reuse third-party material in your article. 
The use of short extracts of text and some other types of material is usually permitted, on a 
limited basis, for the purposes of criticism and review without securing formal permission. If you 
wish to include any material in your paper for which you do not hold copyright, and which is not 
covered by this informal agreement, you will need to obtain written permission from the 
copyright owner prior to submission. More information on requesting permission to reproduce 
work(s) under copyright. 
Disclosure Statement 
Please include a disclosure statement, using the subheading “Disclosure of interest.” If 
you have no interests to declare, please state this (suggested wording: The authors report no 
conflict of interest). For all NIH/Wellcome-funded papers, the grant number(s) must be included 
in the declaration of interest statement. Read more on declaring conflicts of interest. 
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Clinical Trials Registry 
In order to be published in a Taylor & Francis journal, all clinical trials must have been 
registered in a public repository at the beginning of the research process (prior to patient 
enrolment). Trial registration numbers should be included in the abstract, with full details in the 
methods section. The registry should be publicly accessible (at no charge), open to all 
prospective registrants, and managed by a not-for-profit organization. For a list of registries that 
meet these requirements, please visit the WHO International Clinical Trials Registry 
Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information 
among clinicians, researchers, and patients, enhances public confidence in research, and is in 
accordance with the ICMJE guidelines. 
Complying With Ethics of Experimentation 
Research Reporting Guidelines 
Submissions should adhere to current research reporting guidelines. Reporting guidelines, 
checklists, and flow diagrams for many types of studies are available from the  Enhancing the 
Quality and Transparency of Health Research (EQUATOR) network, including CONSORT for 
randomized clinical trials (RCTs) and for pilot and feasibility studies, PRISMA for systematic 
reviews, STROBE for observational studies, SRQR for qualitative research, among others. 
Submissions should include a completed checklist as a supplementary file when this is 
possible. 
Psychology and Health will publish randomized trials only if they have been registered. A 
complete list of acceptable trial registries can be found via the  WHO International Clinical 
Trials Registry Platform. Any differences between registered and reported methods or outcomes 
should be explained in the manuscript. Published protocols should be cited in the manuscript. 
Use of the  Standard Protocol Items: Recommendations for Intervention Trials (SPIRIT) 
checklist  is recommended. For all intervention components, authors are encouraged to use the 
TIDieR Checklist as a supplemental file. 
Please ensure that all research reported in submitted papers has been conducted in an 
ethical and responsible manner, and is in full compliance with all relevant codes of 
experimentation and legislation. All papers which report in vivo experiments or clinical trials on 
humans or animals must include a written statement in the Methods section. This should explain 
that all work was conducted with the formal approval of the local human subject or animal care 
committees (institutional and national), and that clinical trials have been registered as legislation 
requires. Authors who do not have formal ethics review committees should include a statement 
that their study follows the principles of the Declaration of Helsinki. 
Consent 
All authors are required to follow the ICMJE requirements on privacy and informed 
consent from patients and study participants. Please confirm that any patient, service user, or 
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participant (or that person’s parent or legal guardian) in any research, experiment, or clinical trial 
described in your paper has given written consent to the inclusion of material pertaining to 
themselves, that they acknowledge that they cannot be identified via the paper; and that you have 
fully anonymized them. Where someone is deceased, please ensure you have written consent 
from the family or estate. Authors may use this Patient Consent Form, which should be 
completed, saved, and sent to the journal if requested. 
Health and Safety 
Please confirm that all mandatory laboratory health and safety procedures have been 
complied with in the course of conducting any experimental work reported in your paper. Please 
ensure your paper contains all appropriate warnings on any hazards that may be involved in 
carrying out the experiments or procedures you have described, or that may be involved in 
instructions, materials, or formulae. 
Please include all relevant safety precautions; and cite any accepted standard or code of 
practice. Authors working in animal science may find it useful to consult the International 
Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and 
Welfare and Guidelines for the Treatment of Animals in Behavioural Research and Teaching. 
When a product has not yet been approved by an appropriate regulatory body for the use 
described in your paper, please specify this, or that the product is still investigational. 
Submitting Your Paper 
This journal uses ScholarOne Manuscripts to manage the peer-review process. If you 
haven't submitted a paper to this journal before, you will need to create an account in 
ScholarOne. Please read the guidelines above and then submit your paper in the relevant Author 
Centre, where you will find user guides and a helpdesk. 
Please note that Psychology & Health uses Crossref™ to screen papers for unoriginal 
material. By submitting your paper to Psychology & Health you are agreeing to originality 
checks during the peer-review and production processes. 
On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find 
out more about sharing your work. 
Share upon reasonable request:  
Data Sharing Policy 
This journal applies the Taylor & Francis share upon reasonable request data sharing 
policy. Authors agree to make data and materials supporting the results or analyses presented in 
their paper available upon reasonable request. It is up to the author to determine whether a 
request is reasonable. Authors are required to cite any data sets referenced in the article and 
provide a Data Availability Statement. Please note that data should only be shared if it is ethically 
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correct to do so, where this does not violate the protection of human subjects, or other valid 
ethical, privacy, or security concerns. 
At the point of submission, you will be asked if there is a data set associated with the 
paper. If you reply yes, you will be required to provide the DOI, pre-registered DOI, hyperlink, 
or other persistent identifier associated with the data set(s). If you have selected to provide a pre-
registered DOI, please be prepared to share the reviewer URL associated with your data deposit, 
upon request by reviewers. 
Where one or multiple data sets are associated with a manuscript, these are not formally 
peer reviewed as a part of the journal submission process. It is the author’s responsibility to 
ensure the soundness of data. Any errors in the data rest solely with the producers of the data 
set(s). 
Publication Charges 
There are no submission fees, publication fees or page charges for this journal. 
Colour figures will be reproduced in colour in your online article free of charge. If it is 
necessary for the figures to be reproduced in colour in the print version, a charge will apply. 
Charges for colour figures in print are £300 per figure ($400 US Dollars; $500 Australian 
Dollars; €350). For more than 4 colour figures, figures 5 and above will be charged at £50 per 
figure ($75 US Dollars; $100 Australian Dollars; €65). Depending on your location, these 
charges may be subject to local taxes. 
Copyright Options 
Copyright allows you to protect your original material, and stop others from using your 
work without your permission. Taylor & Francis offers a number of different license and reuse 
options, including Creative Commons licenses when publishing open access. Read more on 
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Objective: The purpose of this study was to investigate whether coping strategies (adaptive vs 
maladaptive) mediate the relationship between stigma and wellbeing in people living with 
cervical dystonia. 
Design: A cross-sectional design was used. Adults with cervical dystonia were invited to take 
part in a survey. 114 individuals completed quantitative measures of stigma and coping strategies 
and a holistic exploration of the concept of wellbeing (including health-related quality of life, 
depression, anxiety, stress, and a wellbeing scale). Data were analysed using mediation 
regression analyses. 
Main findings: Mediational regression analyses indicated that maladaptive coping strategies 
(e.g. substance use, behavioural disengagement) mediated the relationship between stigma and 
wellbeing. Adaptive coping strategies (e.g. acceptance, humour) did not mediate the relationship 
between stigma and wellbeing. 
Conclusion: These findings suggest that maladaptive coping may play an important role in 
explaining the relationship between stigma and some aspects of wellbeing in cervical dystonia. 
Coping strategies should be considered within clinical settings to target the relationship between 
stigma and wellbeing. Interventions which focus on different aspects of maladaptive coping (e.g. 
acceptance and commitment therapy for people who are using strategies such as denial or 
experiential avoidance) may be helpful to improve wellbeing. 
Keywords:  Cervical dystonia, spasmodic torticollis, stigma, coping, psychological 
wellbeing  




Dystonia is a movement disorder which involves involuntary, sustained muscle 
contractions leading to repetitive movements and abnormal postures (1). Studies have shown that 
it affects approximately 0.01-0.03% of the population (2,3) and is the third most prevalent 
movement disorder after Parkinson’s disease and essential tremor (4). Although the neurobiology 
of this condition is still not fully understood (5), it has been proposed that dystonia should be 
classified on two axes (6). Axis I includes clinical characteristics such as age of onset and body 
distribution, which is broken down into the following: focal (affecting one body region), 
segmental (affecting two or more adjoining body regions), multifocal (affecting two non-
adjoining or more body regions), generalised (affecting the trunk and two other body regions), 
and hemidystonia (body regions affected are more focussed on one side). Axis II includes what is 
known of the aetiology, including whether it is inherited, acquired or idiopathic dystonia (6). 
Cervical dystonia (CD), also known as spasmodic torticollis, is the most common focal dystonia 
and is characterised by uncontrolled twisting, turning and tilting of the head caused by 
involuntary and often painful contractions of the neck muscles (7). 
In addition to the physical implications, people with dystonia report a range of 
psychological difficulties that impact on their day to day lives. Reports in the literature estimate 
that lifetime prevalence of anxiety and depression for people living with dystonia varies between 
12%-71% (8). There is debate over whether psychological distress is a result of the underlying 
neurobiology associated with the condition, or whether it is secondary to the impact of living 
with a chronic health condition (9,10). There is evidence to suggest it could be a combination of 
both, and that a biopsychosocial framework should be adopted when trying to understand 
psychological distress in this population (11), particularly as distress can impact overall health 
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related quality of life (HRQOL) (12). HRQOL broadly looks at how a condition impacts on an 
individual across physical, social and psychological domains (13,14). 
A range of factors have been shown to correlate with distress and HRQOL, including 
body image (15–19), social participation (7,16), self-esteem (7,16,17) and coping strategies 
(15,16,20,21). In studies of other movement disorders, such as Parkinson’s disease, stigma has 
also been found to play a key role in HRQOL, distress and wellbeing (22,23).  
Stigma is a vital aspect of health research and was originally defined as a feeling of being 
shunned by others for possessing a distinguishing characteristic that is less valued than the social 
norm (24). Stigma can be broken down into two main areas: enacted stigma, which is related to 
discrimination and attitudes from the public; and perceived stigma, which is an internalising of 
enacted stigma by an individual, often leading to feelings of shame and can often occur without 
many instances of enacted stigma (25). Theoretical frameworks of stigma were further expanded 
by Link & Phelan (26) who recognised the role of power inequalities and the relational context 
that enables stigma to occur.  
Perceived stigma has been shown to lead to poorer quality of life (QOL), negatively 
impact health-related outcomes and increase social isolation in people with mental health 
difficulties (27–29). Studies of enacted stigma involving people with epilepsy show that 
frequency of enacted stigma is associated with increased psychological distress and a poorer 
QOL (30–32). Stigma has also been found to predict psychological outcomes in people with 
neurological conditions who present with movement disorders such as Parkinson’s disease and 
multiple sclerosis (23,33,34). Visible characteristics, such as tremors or muscle contractions in 
dystonia, can result in stigmatising social experiences alongside the physical and emotional 
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impact of the condition (35). This in turn can exacerbate the psychological, physical and social 
aspects of the condition (36) and may contribute towards a decrease in overall QOL (37).  
A 2001 study examining the role of stigma in cervical dystonia found that the majority of 
participants reported experiencing ‘some’ or ‘severe’ stigma relating to their condition (38). The 
questionnaire used to examine stigma was created following interviews with participants. 
Although this meant that it had good face validity and was focussed on what was important to 
the 10 participants initially interviewed, it is unclear how generalisable this could be to other 
people living with dystonia. An additional study looking at the perceptions of people without 
dystonia used a scale developed in line with that used by Papathanasiou et al. (38) and revealed 
stigmatising attitudes towards those with cranial and cervical dystonia (39). This suggests that 
enacted stigma may be a part of daily life for this population, particularly those with cervical 
dystonia. Stigma was also a strong theme in recent qualitative research on the experience of 
living with dystonia, with the findings suggesting that stigma impacted on the navigating of 
health services, social connectedness and views of the self (40).  
The role of stigma in relation to psychological outcomes for people with dystonia is 
poorly understood. One study found a significant relationship between stigma and both the 
mental and physical aspects of QOL in people with cervical dystonia (7). Another study found no 
significant relationship between stigma and HRQOL for people with segmental dystonia (41) but 
had a small sample size (n=28). Furthermore, both studies used a stigma scale designed for 
people with bowel cancer (42) which had not been validated for dystonia. Despite some 
emerging evidence for the role of stigma in psychological well-being in dystonia, the picture is 
still unclear and may indicate that there are other factors that could be influencing the 
relationship between the two concepts. 
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Research focussing on other groups who experience stigma has considered the ‘minority 
stress paradigm’ (43), which conceptualises stigma as a stressor above and beyond what non-
stigmatised people endure, leading to difficulties with mental health. This paradigm was further 
developed into a ‘psychological mediation framework’ (44), which integrated the theory of 
minority stress with psychological processes that may result from being stigmatised, and 
therefore contribute to psychological distress. One of these proposed processes was coping 
strategies.  
Coping can be defined as the behavioural, emotional and cognitive strategies employed to 
manage certain stressors (45). It is suggested that coping has an important role to play in the 
adaptation needed due to changes in physical health (46). Similarities have been noted across 
different disease processes in how people cope with the stress of changes in ability, and the 
impact that this then has on emotional distress (47). There are over 400 coping strategies which 
have been classified in various ways within the literature, such as ‘emotion focussed’, ‘problem 
focussed’, ‘approach’, ‘avoidance’, ‘adaptive’ and ‘maladaptive’, without a shared consensus on 
the most appropriate classification (48). In line with research drawn on for the current study, the 
terms ‘maladaptive’ and ‘adaptive’ will be used. It is important to note however, that using these 
terms is not meant to encourage simplistic thinking about ‘bad’ or ‘good’. It is recognised that 
maladaptive coping is often a functional adaptation to chronic stress (49) and that a two factor 
model may not fully capture the complexities related to coping strategies. However, within the 
literature, the use of a two factor model has provided insight into the impact of coping strategies 
on levels of distress (50,51) suggesting there is utility in this approach. In particular, maladaptive 
coping strategies have a greater relationship with distress, whereas adaptive strategies have a 
stronger relationship with wellbeing (50). 
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There is emerging evidence that the experience of stigma can lead to coping behaviours 
which could be considered maladaptive, such as disengagement and substance use, which in turn 
can impact on psychological wellbeing and QOL (52). Coping strategies have also been shown to 
be related to distress in dystonia, with strategies considered maladaptive being related to higher 
levels of depression and anxiety (15,16,20,21). 
Wellbeing has not been examined in dystonia, apart from as an outcome in a singular 
treatment study (53). Wellbeing is usually conceptualised as a combination of functioning well 
and positive affect (54) although it is generally poorly defined within the literature (55). 
However, wellbeing has been shown to be an important predictor of physical health in 
longitudinal research (56,57). It is also suggested that if we only examine distress then there is a 
risk that this might leave important gaps in our understanding of health and QOL (58). 
Although there is a suggested relationship between stigma and QOL, and between coping 
strategies and psychological distress, to date the relationship between stigma, coping and 
psychological outcomes has not been examined in people with dystonia. Consequently, this study 
will investigate, via survey, the relationship between stigma and psychological wellbeing, then 
also investigate whether coping mediates this relationship in a cohort of people with cervical 
dystonia. The focus will be on a community sample of people with cervical dystonia as this is the 
most common type of dystonia. It is hoped that by furthering the understanding of these 
concepts, clinicians will be able to better support the wellbeing of those living with this chronic 
condition. This in turn could have an impact on overall QOL.  
For the purposes of this study, well-being is characterised by low levels of distress 
labelled as anxiety, stress and depression, as well as an elevated score on a measure of well-
being. A measure of HRQOL specific to cervical dystonia is also included to gain a holistic 
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picture of satisfaction across a variety of life domains. The model being tested will be of 
theoretical interest and has potential implications for the field of clinical psychology both on an 
individual level within formulations and at a more systemic and societal level (59).   
Based on previous research the study hypotheses were as follows: 
1. Higher levels of stigma will be associated with higher maladaptive but lower 
adaptive coping strategies. 
2. Higher levels of stigma will be associated with lower levels of psychological 
well-being, increased levels of distress (depression, anxiety and stress) and 
reduced HRQOL.   
3. The use of maladaptive coping strategies will be associated with increased 
distress, lower wellbeing and lower HRQOL. 
4. Maladaptive coping will mediate the relationship between stigma and 
psychological well-being, levels of distress and HRQOL. 





This study was a cross-sectional survey using quantitative measures. The data were 
quantitatively examined, and non-parametric bivariate correlations were carried out. Following 
this, a parallel mediation analysis was conducted using Hayes process tool (60) within SPSS to 
test the theoretical model that coping strategies mediate the relationship between stigma and 
psychological wellbeing (including distress) and HRQOL (see figure 2-1). 
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[Figure 2-1 about here]. 
Participants 
Participants were recruited via two dystonia charities: The Dystonia UK 
(https://www.dystonia.org.uk/) and Dystonia Ireland (http://www.dystonia.ie/). Recruitment took 
place between 3rd September 2019 and 27th January 2020 via advertisements on the charities’ 
social media profiles. Two participants contacted the researcher to request paper copies of the 
survey which were then returned in pre-paid envelopes and manually inputted into the survey 
software Qualtrics. The rest of the participants completed the survey online. A total of 143 people 
completed the survey. The data from 29 participants were removed due to missing data (see 
analysis for details). This left 114 participants to be included in the study. 
Calculations were conducted prior to recruitment to determine sample size required. For a 
medium effect (0.36) in both paths (stigma to coping (α) and coping to psychological outcomes 
(β)) using a bias-corrected bootstrap mediation model, approximately 71 participants were 
required for 80% power, rising to 115-116 if the α or β path coefficient has a small-medium 
effect (0.26) (61). Previous research looking at the relationship between stigma and coping have 
found small-medium effects for adaptive coping and large effects for maladaptive coping, 
suggesting powering the study for a small-medium effect should be sufficient (51). It is not 
possible to take the effect size for β from previous research as this requires the identical model 
(and the author is not aware of such research). Therefore, the sample size of 114 was deemed 
acceptable. 
Inclusion criteria 
Individuals were eligible to take part if they:  
• Self-reported a diagnosis of cervical dystonia.  
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• Were aged 18 or over. 
• Could complete the measures alone or with support. 
• Had sufficient understanding of written English to take part (as the questionnaires were in 
English). 
Exclusion criteria 
Potential participants were excluded if they: 
• Had dystonia following a serious injury. 
• Had another significant illness/condition that affected their visible appearance. 
Procedure 
The study was designed in consultation with two members of Dystonia UK who provided 
feedback via email on the content and accessibility of the survey. Adaptations were made based 
on their feedback, including the change of wording on some of the questions and explanations.  
Once ethical approval had been obtained the study was advertised on the Facebook and Twitter 
pages for Dystonia UK and Dystonia Ireland as well as in communications that were cascaded to 
local groups. People who followed the link were presented with an information and consent page 
explaining the purpose of the study, and invited to complete an online survey (using Qualtrics, a 
web-based survey tool) or to contact the researcher to request a paper copy to be sent via post 
(for information page and survey see section 4: Ethics and Appendices). Data from the online 
survey were gathered electronically, and data from the hard copies were inputted immediately 
into the electronic dataset. The hard copies of the questionnaire were safely and immediately 
destroyed.    
Materials 
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This study utilised an online survey which was also available in paper form. Alongside 
the validated measures it also asked questions regarding demographic and clinical information to 
describe the sample. The demographic questionnaire asked about age, gender, ethnicity, work 
status, relationship status and living arrangements. The clinical questionnaire asked about age of 
onset, duration, time since diagnosis, medication, disease severity, whether the individual was 




The predictor variable, stigma, was measured by the 24-item Stigma Scale for Chronic 
Illness (SSCI). This scale was developed for people with chronic neurological disorders and 
measures both felt stigma and enacted stigma (62). This scale is divided into two subscales of 
internalised stigma and enacted stigma. All questions are answered using a Likert scale from one 
(never) to five (always). The total score of both scales measures overall stigma and can range 
from 24-120, with a higher score suggesting more stigma. It has been shown to have a good level 
of internal consistency (Cronbach’s alpha = 0.96) (62) and good content validity (63).   
Mediator variables 
Coping  
The two mediator variables in this study were adaptive coping and maladaptive coping. 
These were both measured using the brief COPE (64). This has 14 subscales each including two 
items. Although the subscales of the brief COPE have been categorised in various ways in the 
literature, this study used the two-category model developed by Meyer (50), which divides the 
subscales into adaptive and maladaptive coping strategies. All questions were answered using a 
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Likert scale from one (I haven’t been doing this at all) to four (I’ve been doing this a lot). 
Adaptive coping included the subscales ‘active coping’, ‘use of emotional support’, ‘use of 
instrumental support’, ‘positive reframing’, ‘planning’, ‘humour’, ‘acceptance’ and ‘religion’. 
This scale gave scores ranging from 16-64 with a higher score indicting more frequent use of 
these strategies. Maladaptive coping included the subscales ‘self-distraction’, ‘denial’, 
‘substance-use’, ‘behavioural disengagement’, ‘venting’ and ‘self-blame’. This scale gave scores 
ranging from 12-48 with a higher score indicating more frequent use of these strategies. 
Although not used specifically in dystonia, the brief COPE has been used with other neurological 
conditions such as Parkinson’s disease (65) and multiple sclerosis (66).  For the current study it 
showed good reliability with Cronbach’s alpha values of 0.81 for the maladaptive subscale and 
0.84 for the adaptive subscale 
Outcome variables 
Well-being, distress and HRQOL 
Three separate measures were included to address the outcome of wellbeing. The first 
was the short version of the Depression Anxiety Stress Scale–21 (DASS-21) (67,68). This is a 
21-item scale with three subscales looking at stress, anxiety and depression. Each subscale has 7 
questions which are rated on a Likert scale from zero (not at all) to three (most of the time).  
Each subscale score ranges from 0-21 with a high score indicating higher levels of stress, anxiety 
or depression. Although not used previously with people living with dystonia, it has been used 
with other neurological conditions which present with movement disorders such as Parkinson’s 
disease (69) and multiple sclerosis (70). It has good reliability with subscale Cronbach's 
alpha values of 0.81 (depression), 0.89 (anxiety) and 0.78 (stress) (71). 
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The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) (72) is a 14-item 
validated measure of wellbeing which focusses on positive aspects of mental health. This has 
been used as an outcome in a previous study looking at the effects of a cognitive behavioural 
intervention for people living with dystonia (53) and more recently in a large survey of people 
living with Parkinson’s disease (73). In addition, it is considered easy to complete and useful for 
general population samples. Each item is scored using a Likert scale from one (never) to five 
(always) giving a total score range of 14-70. In this scale a higher score indicates higher levels of 
wellbeing. The WEMWBS has been shown to have a strong internal consistency and a 
high Cronbach's alpha of 0.89 (72). 
The measure of overall HRQOL was the Cervical Dystonia Impact Profile (CDIP-58) 
(74) which is a 58-item scale measuring the impact of CD across eight domains: head and neck 
symptoms, pain and discomfort, upper limb activities, annoyance, sleep, walking, mood and 
psychosocial functioning. A higher score shows a lower HRQOL. This measure has been shown 
to have good validity and reliability with a Cronbach’s alpha of 0.92 (75).  
To help describe the sample, disease severity was also explored using the Functional 
Disability Questionnaire (76). This is a 27-item scale developed to measure the impact of 
dystonia on activities of daily living with a higher score indicating higher levels of disability. It 
has been suggested by the original authors of the measure that scores above the median of 42 
indicate a moderate to severe level of disability relating to dystonia (16).The construct and 
concurrent validity of the scale, along with test-retest reliability and internal consistency have 
been shown to be high with a Cronbach’s alpha of 0.92 (76).  




Ethical approval was obtained for this study via the Lancaster University Faculty of 
Health and Medicine Research Ethics Committee (reference FHMREC18109 – see section 4: 
Ethics and appendices for ethical approval letter). An amendment was applied for (and granted) 
in October 2019 to expand the recruitment strategy to enable both charities to be able to advertise 
through all channels available to them and to be able to approach other dystonia relevant online 
organisations to request the advert be shared through their channels. Dystonia UK also requested 
a video that they could use to disseminate information about the study.  
Efforts were made to consider any potential distress that may be caused by participating 
in this study. Contact details were given for places that could provide support should any issues 
arise. Additionally, it was made clear prior to starting the study and providing informed consent 
that individuals could stop at any time during the survey. Although, due to the anonymity of 
participation, their data could not be removed after they had agreed to take part. This information 
was provided before informed consent was obtained to be included in the study. 
Data analysis 
One hundred and forty-three participants opened the survey and completed the consent 
process. Out of these, 13 had only completed the demographics and a further four had stopped 
after only completing the first measure. Additionally, five participants had not completed any of 
the measures of wellbeing. These data were therefore removed from the dataset (n=22) leaving 
121 participants. A missing values analysis was conducted, and one case was missing multiple 
(more than two) data points from multiple measures, so this case was also removed from 
analysis. Six further participants had missed completing full scales that were essential to the 
analysis (SSCI; n=3, DASS21; n=3) so these were also removed leaving 114 participants. The 
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missing SSCI data may have been due to an error with the survey software, and the DASS21 was 
situated towards the end of the survey so people may have exited before completing it. There 
were no significant differences in the demographic and clinical characteristics between those 
who completed all the measures and those who did not. Of the remaining cases, none were 
missing more than two data points from any measure, so they were retained, and mean 
substitution was used to impute the missing data points.   
Absolute values for z-scores were calculated for each variable to check whether they 
were consistent with a normal distribution (77). This analysis identified probable outliers (with 
scores of >2.58) in three of the variables: two cases on the SSCI (1.7%), two cases on the 
maladaptive subscale of the brief COPE (1.7%) and one case on the anxiety subscale of the 
DASS21 (0.8%). ‘Winsorising’ the data on these scales had little effect on the results of the 
analyses so the original data were retained. 
Data distributions were inspected visually for normality using histograms. The 
‘maladaptive coping’, ‘depression’, ‘anxiety’ and ‘stress’ data were all skewed towards lower 
scores, so Spearman’s rho correlation coefficients were calculated to assess the direction and 
strength of relationships between predictor, mediator and outcome variables. Before conducting 
the mediation analyses, the linear and multiple regression scatterplots corresponding to each 
analysis in the mediation were also visually inspected to test the assumptions of linearity and 
homoscedasticity of residuals, with standardised residuals plotted against standardised predicted 
values (77). Q-Q plots were used to assess the assumption of normality of error distributions 
(77). All relationships appeared to respect the assumptions of linearity, homoscedasticity of 
residuals and normality of error distributions. 
Finally, a series of mediation analyses were conducted using Hayes’ Process Tool (78). In 
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each analysis, 5000 bootstrap samples were used to estimate the confidence intervals, enabling it 
to cope with non-normal data distributions (61). In all models, stigma as measured by the SSCI, 
was the independent variable (IV) and two types of coping strategies (adaptive and maladaptive 
as measured by the Brief COPE) were tested together as parallel mediators. In model 1, HRQOL 
as measured by the CDIP-58 was used as the dependent variable (DV). In model 2, wellbeing as 
measured by the WEMWBS was used as the DV. In model 3 stress as measured by the stress 
subscale of the DASS-21 was used as the DV. In model 4, anxiety as measured by the anxiety 
subscale of the DASS-21 was used as the DV. In model 5 depression as measured by the 
depression subscale of the DASS-21 was used as the DV. The indirect effect of coping style was 
deemed significant if the 95% bootstrap confidence interval did not contain zero (60). 
RESULTS 
A summary of participant characteristics is included in Table 2-1. 
[Table 2-1 about here]  
 
Of the 114 participants in the sample, 21 identified their gender as being male (18%) and 
93 identified as female (82%). The mean age of the sample was 52.39 years and ages ranged 
from 24-77 years. Most participants (111; 97%) identified their ethnicity as white (English, Irish, 
British, Scottish, Welsh, Other), one as mixed white & black Caribbean and two as ‘other’. Half 
the participants (57) reported being in either full time or part time work, 19 (17%) were retired 
and 38 (33%) reported they were not currently working.   
Clinical characteristics 
The participants reported a mean age of symptom onset of 34.49 years (SD 12.86) and a 
mean age of diagnosis of 42.60 years (SD 11.89). Most of the participants (88%) reported they 
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had received botulinum toxin injections to manage the symptoms of cervical dystonia and 63 
participants (55%) reported taking prescribed medication to manage symptoms. Approximately 
half of the participants (54%) reported having comorbid physical or mental health conditions. 
For those that completed the FDQ (n=111) the mean score was 72.27 (SD 20.9) and a range of 
25-12.   
Measures of stigma, coping and wellbeing 
Table 2-2 shows the means, standard deviations (SD) and Cronbach’s alpha of 
psychometric measures for the sample.  
[Table 2-2 about here] 
[Table 2-3 about here] 
Table 2-3 shows the frequencies and cut offs for measures of distress using the DASS-21.  
These results suggest that 48.3% (n=55) of the sample reported moderate to extremely severe 
levels of depression, 55.3% (n=63) showed moderate to extremely severe levels of anxiety, and 
36.8% (n=42) of the sample reported moderate to extremely severe levels of stress.  Additionally 
the results from the WEMWBS, which indicate levels of wellbeing, showed that 43% (n=49) 
scored lower than 40 which is the level that UK National Health Service direct uses as a cut off 
score to indicate lower levels of wellbeing (79).  
The mean score for adaptive coping was 36.1 and for maladaptive coping was 22.6.  
Although there are no cut offs for this scale, higher scores indicate more frequent use of the 
different coping strategies.  
The mean score for the measure of stigma for this sample was 61.33. Higher scores 
indicate increased levels of reported stigma. These scores were higher than the normative sample 
mean of 42.7 which was found in participants with a range of other neurological conditions (62).  
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The CDIP-58 scaled mean was 50.24 which is similar to that seen in other research on 
cervical dystonia (80,81) and suggests a significant impact of CD on overall HRQOL.  
Correlational analyses 
Non-parametric bivariate correlations indicated that the relationships between all the 
scales, apart from the adaptive subscale of the Brief COPE, were significant at the p<0.01 level 
with medium to large effect sizes (see table 2-4). Specifically, higher levels of stigma correlated 
with more frequent maladaptive coping (r =.637), lower HRQOL (r =.641), lower levels of 
wellbeing (r =-.488), higher levels of stress (r =.529), higher levels of anxiety (r =.484) and 
higher levels of depression (r =.589), but not use of adaptive coping (r =.04; p>0.05). More 
frequent use of maladaptive coping strategies correlated with lower HRQOL (r =.528), lower 
levels of wellbeing (r =-.427), higher levels of stress (r = .559), higher levels of anxiety (r 
=.538), and higher levels of depression (r =.631). More frequent use of adaptive coping 
strategies only correlated with an increase in wellbeing with a medium effect size (r =.331, 
p<.01).   
Gender was found to significantly correlate with the anxiety subscale of the DASS-21 (r 
=.198; p<0.05) and the CDIP-58 (r =.219; p<0.05) with females scoring higher on both of these 
measures with a small effect size. This suggests that females in this sample had higher levels of 
anxiety and a lower HRQOL. 
[Table 2-4 about here] 
Mediation regression analyses 
Five parallel mediation models (60,82) were used to examine the indirect effect of both 
adaptive and maladaptive coping on different measures of wellbeing: HRQOL, CDIP-58 (Model 
1); wellbeing, WEMWBS (Model 2); stress, DASS21-S (Model 3); anxiety, DASS21-A (Model 
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4); and depression, DASS21-D (Model 5) (see Figure 2-2). For a summary of results see Table 2-
5. 
[Figure 2-2 about here] 
[Table 2-5 about here] 
Model 1 – HRQOL 
Results from the parallel mediation analysis indicate that stigma was indirectly related to 
HRQOL through its relationship with maladaptive coping. Increased stigma was related to more 
frequent use of maladaptive coping strategies (a2=.246, p<.001), and more frequent maladaptive 
coping was subsequently related to a lower HRQOL (b2=2.006, p <.01). Mediation analysis 
indicated that the 95% confidence interval of the indirect effect through maladaptive coping 
(a2b2=.492) was entirely above zero (0.136 to 0.857). In contrast, increased stigma was not 
related to more frequent use of adaptive coping strategies (a1=.003) and adaptive coping was not 
related to HRQOL (b1=-.456). The indirect effect through adaptive coping was not significantly 
different to zero (a1b1=-.001; 95%CI -.060 to .074; see table 2-E for the effect sizes associated 
with these pathways). The direct effect between stigma and HRQOL was found to remain 
significant when controlling for the effect of the mediational variables of coping strategies (c’ = 
1.367, p<.001).    
Model 2 – wellbeing 
The analysis indicated that stigma was indirectly related to wellbeing through its 
relationship with maladaptive coping. Increased stigma was related to more frequent use of 
maladaptive coping strategies (a2 = .246, p<.001), and more frequent maladaptive coping was 
subsequently related to a lower wellbeing (b2 = -.549, p<.005). Mediation analysis indicated that 
the 95% confidence interval of the indirect effect through maladaptive coping (a2b2 = -.135) was 
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entirely below zero (-.231, to -.050). In contrast, increased stigma was not related to more 
frequent use of adaptive coping strategies (a1=.003) but more frequent adaptive coping was 
related to higher wellbeing (b1= .372, p<.001). However, the indirect effect through adaptive 
coping was not different to zero (a1b1= .001; 95%CI -.037 to .038). The direct effect between 
stigma and wellbeing remained significant when controlling for the effect of the mediational 
variables of coping strategies (c’ = -.194, p<.005).    
Model 3 – stress 
The analysis indicated that stigma was indirectly related to stress through its relationship 
with maladaptive coping. Increased stigma was related to more frequent use of maladaptive 
coping strategies (a2 = .246, p<.001), and more frequent maladaptive coping was subsequently 
related to higher levels of stress (b2 = 0.371, p<.001). Mediation analysis indicated that the 95% 
confidence interval of the indirect effect through maladaptive coping (a2b2 = .091) was entirely 
above zero (.050 to .137). In contrast, increased stigma was not related to more frequent use of 
adaptive coping strategies (a1=.003) and adaptive coping was not related to stress (b1= -.020). 
The indirect effect through adaptive coping was not different to zero (a1b1= .000; 95%CI 
-.004, .005). The direct effect between stigma and stress remained significant when controlling 
for the effect of the mediational variables of coping strategies (c’ = .061, p<.05).    
Model 4 – anxiety 
The analysis indicated that stigma was indirectly related to anxiety through its 
relationship with maladaptive coping. Increased stigma was related to more frequent use of 
maladaptive coping strategies (a2 = .246, p<.001), and more frequent maladaptive coping was 
subsequently related to higher levels of anxiety (b2 = 0.308 p<.001). Mediation analysis 
indicated that the 95% confidence interval of the indirect effect through maladaptive coping (a2b2 
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= .076) was entirely above zero (.035 to .116). In contrast, increased stigma was not related to 
more frequent use of adaptive coping strategies (a1=.003) and adaptive coping was not related to 
anxiety (b1= -.030). The indirect effect through adaptive coping was not different to zero 
(a1b1= .000; 95%CI -.005, .005). The direct effect between stigma and anxiety remained 
significant when controlling for the effect of the mediational variables of coping strategies (c’ 
= .091, p<.005).    
Model 5 – depression 
The analysis indicated that stigma was indirectly related to depression through its 
relationship with maladaptive coping. Increased stigma was related to more frequent use of 
maladaptive coping strategies (a2 = .246, p<.001), and more frequent maladaptive coping was 
subsequently related to higher levels of depression (b2 = .489, p<.001). Mediation analysis 
indicated that the 95% confidence interval of the indirect effect through maladaptive coping (a2b2 
= .120) was entirely above zero (.075 to .172). In contrast, increased stigma was not related to 
more frequent use of adaptive coping strategies (a1=.003) but more frequent adaptive coping was 
related to lower levels of depression (b1= -.135, p<.005). The indirect effect through adaptive 
coping was not different to zero (a1b1= .000; 95%CI -.016, .014). The direct effect between 
stigma and depression remained significant when controlling for the effect of the mediational 
variables of coping strategies (c’ = .091, p<.01).       
Discussion 
The current study aimed to examine associations between stigma, coping and 
psychological wellbeing for people living with CD. The findings suggested that higher levels of 
stigma were related to more frequent use of maladaptive coping strategies, lower wellbeing, 
lower HRQOL and higher levels of distress. More frequent use of maladaptive coping strategies 
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were related to lower levels of wellbeing, lower HRQOL and higher levels of distress. Adaptive 
coping was not related to stigma or distress, but more frequent use of adaptive coping strategies 
were related to higher levels of wellbeing. In all the mediation models, maladaptive coping 
mediated the relationship between stigma, HRQOL and wellbeing. Adaptive coping did not 
mediate the relationship between stigma and any of the outcomes.  
This study was conducted with a cohort of adults living with CD. The results suggested 
that, according to the cut-offs on the DASS, 48.3% of the current sample had moderate to 
extremely severe depression, 55.3% had moderate to extremely severe anxiety and 36.8% had 
moderate to extremely severe levels of stress. These rates of distress are towards the high end of 
what other studies specifically looking at CD have reported, with rates of depression ranging 
from 16.4%-52.3% (15,16,76,83,84) and anxiety ranging from 21.7%-50% (15,83,84).  
The mean wellbeing scores for this sample (41.68) were lower than the general 
population (49.7-52.3 across England and Scotland) (85), lower than a large scale survey of 
people with Parkinson’s disease (45.2) (73) and a baseline measure in a dystonia cognitive 
behavioural therapy (CBT) study (44.7) (53). This suggests that the current sample might 
experience lower wellbeing than would typically be seen in dystonia. However, as wellbeing has 
not been thoroughly examined in this population, and the study did not have a control group to 
permit direct comparisons, more research is needed to further understand how dystonia impacts 
this. In addition, the scores on the FDQ suggested that the CD population in the current study 
self-reported high levels of disability with a mean score of 72.27. This is higher than has been 
indicated in some other research using the same scale in dystonia (16,17) which reported means 
of 44.1 and 50.3 respectively, but lower than one more recent study (mean 82.6) (86).  The high 
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levels of disability in the current study may be one of the factors relating to the levels of distress 
and wellbeing reported in the current study.   
  The mean scores for both adaptive and maladaptive coping were lower than found in a 
student population using the same measure and categorisation (51), suggesting that those who 
took part in this study used both adaptive and maladaptive strategies with less frequency than the 
student population. The mean score for the measure of stigma for this sample was 61.33. This is 
higher than has been found in other populations such as stroke (mean = 45.21) and multiple 
sclerosis (mean range 36.45–47.44) (87,88), suggesting that those in the current study experience 
a high amount of stigma. It is also the first time this scale has been used specifically with CD. 
However, it is  important to consider the findings relating to distress and stigma with caution due 
to the data being collected via an online questionnaire and the lack of a comparison group, so 
further study with control/comparison groups may elucidate these differences further  
The results supported the hypothesis that stigma is associated with higher frequency of 
maladaptive coping with a large effect size. Having a sense of feeling devalued by society 
through either direct experience of stigma, or the internalising of others’ attitudes, can lead to an 
increased use of maladaptive coping strategies with the aim of alleviating levels of distress 
(44,51). Despite stigma being associated with higher levels of maladaptive coping, it was not 
found to be associated with lower levels of adaptive coping which does not support previous 
research relating to the relationship between stigma and coping strategies (89). However, a study 
examining HIV related stigma and distress also found similar results in that experienced stigma 
was correlated with maladaptive, but not adaptive coping (90). Additionally research looking at 
the mental health of students found that internalised stigma was also not correlated with adaptive 
coping (51). It may be the case that, although stigma may increase the likelihood of adopting 
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maladaptive coping strategies, this does not mean that it will decrease the use of any existing 
adaptive coping strategies.  
As hypothesised, and in line with previous research in dystonia, stigma was associated 
with lower HRQOL (7). Stigma was also associated with increased psychological distress which 
is in line with previous research into Parkinson’s disease, where higher levels of stigma were 
related to increased levels of distress (22,23,91). It has also been found that higher levels of 
stigma are related to lower levels of wellbeing in those with head, neck and lung cancer (92). 
Maladaptive coping was also found to be associated with increased levels of distress, 
lower HRQOL and lower levels of wellbeing. This echoes previous research which has looked at 
maladaptive coping in relation to distress in dystonia (15,16,20,21), although the HRQOL and 
wellbeing findings specifically are novel.  
Adaptive coping was not found to be significantly associated with measures of 
psychological distress (stress, anxiety or depression) or HRQOL. It was however, associated with 
the specific measure of wellbeing. A meta-analysis on coping strategies to regulate emotions 
found that the association between adaptive coping and distress was weaker than the association 
between maladaptive coping and distress (93), suggesting that the different strategies are not 
equal in their contribution to, and maintenance of distress. Research into the concept of 
psychological wellbeing has identified that this is more than an absence of psychological distress 
(94). Despite there often being an inverse correlation between wellbeing and distress, these are 
often moderate at best (55,95,96). This suggests they are separate rather than opposite constructs.  
Further support for this comes from the evidence that wellbeing and distress have distinct 
biological features (97). This might be why the findings for adaptive coping were specific to 
STIGMA COPING AND WELLBEING IN DYSTONIA   
 
2-25
wellbeing and, whilst use of such strategies might not reduce distress, they may be an important 
consideration in improving overall wellbeing.  
When examined through a psychological mediation framework, maladaptive coping was 
found to mediate the relationship between stigma and distress, wellbeing and HRQoL which is in 
line with previous research in other populations that have explored this model (51,90). However, 
adaptive coping was not found to mediate the relationship between stigma and wellbeing in any 
of the psychological mediation models examined. This is contrary to previous research which 
found that adaptive coping mediated the relationship between stigma and psychological 
wellbeing or distress in students (51), or that it played a role in reducing symptoms of depression 
(98). Thus, the results from the current study only partially support the theory that coping 
strategies are processes which impact on wellbeing when trying to manage stress relating to 
stigma (44,51). 
Rinehart et al. (90) also found no evidence for the mediating role of adaptive coping 
between stigma and psychological distress in a sample with HIV. They suggested that adaptive 
coping may serve more as a moderator that dampens the adverse effects of stigma. Support for 
this idea was found in another study which showed that adaptive coping was a moderating effect 
between HIV related stigma and medication adherence (99). Additionally, positive reframing 
(one of the sub categories of coping in the scale used in this study) has been shown to be a 
protective factor when trying to manage the stress associated with stigma in a study looking at a 
CBT intervention (100), so there may be benefit in future research of considering the separate 
coping strategies within the scale as opposed to grouping based on the two-factor model. Rather 
than the type of coping, how and when strategies are used may be more important when 
considering the impact on distress (101). 
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The psychological mediation framework (44) which provided the theoretical basis for the 
mediation model in this study was developed in the context of sexual minority stigma. Although 
the model has been applied in other areas such as HIV (102) and mental health (51) this is the 
first time that it has been applied to a health condition with a visible difference. The framework 
has been considered, via a systematic review, in relation to people living with obesity, another 
visible difference that is highly stigmatised (103) but to date this has remained hypothetical and 
not yet empirically tested.  
Clinical implications 
As indicated here and elsewhere (7,8,38) people with dystonia can experience high levels 
of stigma and psychological distress, highlighting the need to consider these difficulties when 
working clinically with this population. A review of the literature highlighted that there is very 
little evidence for psychological interventions in dystonia (104). CBT is often the model of 
choice when managing anxiety and depression in this population (11) and there is some evidence 
for its effectiveness (53) although care should be given when working with distress that is related 
to stigma as negative responses and scrutiny from others are a reality for many people living with 
dystonia (38).  
The results suggest the coping strategies have an important role to play in the relationship 
between stigma and distress. Developing skills relating to coping have been shown to be 
beneficial to mental health (105).  These skills can be modelled and developed within 
psychological therapy both within group formats (106) and, individually using approaches such 
as Acceptance and Commitment Therapy (ACT).  An important focus of ACT is behaviour 
change processes and valued action (107) which could help facilitate the development of 
alternative coping strategies, as well as promoting wellbeing (108).  
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On a more systemic level, initiatives that target the reduction of stigma relating to this 
condition may also decrease distress, improve wellbeing and enhance HRQOL. Stigma towards 
those with CD has been evidenced in the research (39) and the findings in this study suggest that 
the experiences of stigma from others and psychological distress are interrelated. A review on 
interventions for reducing health related stigma suggested that multiple levels of involvement 
should be considered including within the community, with those around the individual and at 
government and structural levels (109). For people with CD this might include the involvement 
of experts by experience in the design of any policies, providing training to health professionals 
to increase awareness of this condition and increasing public awareness. 
Strengths and limitations 
The strengths of using a cross-sectional online survey methodology included an ease of 
access for participants, a minimisation of missing data and a geographically diverse sample.  
However, there are also some limitations. The majority of respondents were White British and 
female. Previous research has suggested a higher rate of females than males living with CD 
ranging from 61%-75% (110–112) though this is still considerably lower than the 82% of 
females in the current study which could affect generalisability across genders. Ethnicity is less 
frequently reported in studies on CD but in one study examining 66 people with CD they 
estimated the prevalence of white people with the condition to be 1.23 per 100,000 people and 
other races to be 0.15 per 100,000 people (113). 
Although the option to receive the survey in paper form was available to participants, the 
advertisement was primarily online which may have excluded people who were unable to access 
or use computer technology. This could introduce a risk of bias to the study as younger people 
are more likely to take part in online research (114), although the mean age (52.3 years) was 
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similar to another UK study which recruited from an epidemiological study in the north of 
England (56.1 years) (17).  
Categorising the concept of coping into two factors also has its limitations as the 
complexities and nuances of coping strategies can remain overlooked (48).  A way to capture 
these would be to look at each strategy individually. However, as one of the purposes was to test 
the theoretical model it was more practical to use a simplified categorisation.  
Hayes (78) discussed limitations in how findings from cross-sectional mediation are 
interpreted, as the direction of any relationships cannot be inferred. Therefore, although there 
were significant findings in this study, it cannot be assumed that stigma causes people with CD 
to cope with the stress in unhelpful ways which in turn causes them to have lower levels of 
psychological wellbeing. Rather, it appears there are interactions between the conceptualisations 
of stigma, coping and wellbeing, and it may be the case that some of these are bi-directional or 
that there are other factors also influencing these relationships.  
Research Implications 
Given the limited research into the impact of stigma for people living with dystonia, and 
this being identified as an important aspect of their experience (40), it would be useful to build 
on the initial findings within this study to further explore the relationship between stigma and 
psychological wellbeing. This may be done through looking at the subscales of enacted and 
perceived stigma as well as examining in more detail any potential protective role of adaptive 
coping strategies. In addition, research into clinical interventions surrounding coping and stigma 
would be beneficial for this population.  
As mentioned, there are some limitations to categorising coping into two factors. It would 
therefore be useful to further explore the experiences of coping in those with dystonia utilising a 
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qualitative methodology. This could then help inform decisions on the categorisation of coping 
strategies within quantitative research. A longitudinal methodology would be useful to explore 
any temporal and/or causal links between stigma and wellbeing in dystonia. It would also be 
useful to replicate this study with a more diverse population sample. This could be done by 
recruiting from existing epidemiological samples or via movement disorder clinics. 
Conclusions 
The current study has provided valuable insights into the role of stigma and coping 
strategies on psychological wellbeing and HRQOL in CD. It is also the first study to apply the 
psychological mediation framework (44) in the context of a physical health condition with a 
visible difference. Levels of stigma were related to more frequent use of maladaptive coping, 
lower wellbeing, lower HRQOL and higher levels of distress. Maladaptive coping was related to 
lower levels of wellbeing, lower HRQOL and higher levels of distress. Adaptive coping was not 
related to stigma or distress, but more frequent use of adaptive coping was related to higher 
levels of wellbeing. In all the mediation models, maladaptive coping mediated the relationship 
between stigma, HRQOL and wellbeing. Adaptive coping did not mediate the relationship 
between stigma and any of the outcomes.  Based on these findings and those in the wider 
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Table 2-1  
Sample Demographics 
Table 2-1 
Sample demographics (n=114) 
 n % Mean Standard 
Deviation 
Range 
Age (years)   52.39 10.01 24-77 
Age of symptom onset   37.49 12.86 9-67 










   
Ethnicity: 
 White English 
 White Welsh 
 White Scottish 
 White British 
 White Irish 
 Other White Background 

























   
Partnership status: 
 Single 













   
Living arrangements: 
 Alone 










   
Work Status: 
 Employed full time 
 Employed part time 












   









   
Note: Percentages are rounded to the nearest whole number, except for percentages less than one, 
which are rounded to the nearest 0.5%. FDQ = Functional Disability Questionnaire.  Scores 
above the median of 42 indicate a moderate to severe level of disability relating to dystonia 
  




Means, SDs and Cronbach’s alpha of psychometric measures 
Table 2-2 
Means, SDs and Cronbach’s alpha of psychometric measures 
 
Measure M(SD) Sample range Cronbach’s 
alpha 
SSCI 61.33 (19.43) 25-115 0.95 
COPE-M 22.58 (6.97) 12-43 0.81 
COPE-A 36.41 (9.26) 16-57 0.84 
CDIP-58 174.56 (54.17) 67-286 0.98 
WEMWBS 41.68 (11.97) 14-70 0.95 
DASS-S 8.60 (5.42) 0-21 0.89 
DASS-A 6.69 (5.57) 0-21 0.87 
DASS-D 8.60 (6.30) 0-21 0.93 
 
Note: SSCI, Stigma Scale for Chronic Illness; COPE-M, COPE/Maladaptive subscale; 
COPE-A, COPE/Adaptive subscale; CDIP-58, Cervical Dystonia Impact Profile; WEMWBS, 
Warwick-Edinburgh Mental Wellbeing Scale; DASS21-S, Depression Anxiety Stress 
Scale/Stress subscale; DASS21-A, Depression Anxiety Stress Scale/Anxiety subscale; DASS21-
D, Depression Anxiety Stress Scale/Depression subscale.  Higher scores mean a higher level of 
what is being measured on each of the scales apart from the CDIP-58 where a higher score 
indicated a lower HRQOL.  
  




Cut offs and frequency of severity of distress as measured using the DASS-21 
 
Table 2-3 
Cut offs and frequency of severity of distress as measured using the DASS-21 – score (n; %) 
 Depression Anxiety Stress 
Normal 0-9 (50; 43.9%) 0-7 (47; 41.2%) 0-14 (53; 46.5%) 
Mild 10-13 (9; 7.9%) 8-9 (4; 3.5%) 15-18 (19; 16.7%) 
Moderate 14-20 (24; 21.1%) 10-14 (21; 18.4%) 19-25 (17; 14.9%) 
Severe 21-27 (10; 8.8%) 15-19 (9; 7.9%) 26-33 (14; 12.3%) 
Extremely Severe 28+ (21; 18.4%) 20+ (33; 30.0%) 34+ (11; 9.7%) 
    
Total moderate – extremely 
severe 
14+ (55; 48.3%) 10+ (63; 55.3%) 19+ (42; 36.8%) 
Note: Calculated using the cut-offs proposed by (68) for the DASS.  For DASS-21 scores are 
multiplied by two to calculate final score. Percentages rounded to one decimal place.  
  





Non-parametric bivariate correlations among variables 
 
Table 2-4 
Non-parametric bivariate correlations among variables 
 Age Gender SSCI COPE-M COPE-A CDIP-
58 
WEMWBS DASS21-S DASS21-A DASS21-D 
Age 1 -0.17 -.183 -.158 -.030 .019 .151 -.094 -.030 -.073 
Gender  1 -.016 .107 -.064 .219* -.078 .133 .198* .142 
SSCI   1 .637** .041 .641** -.488** .529** .584** .589** 
COPE-M    1 .154 .528** -.427** .559** .538** .631** 
COPE-A     1 -.068 .331** .019 -.003 -.145 
CDIP-58      1 -.707** .686** .670** .729** 
WEMWBS       1 -.539** -.511** -.669** 
DASS21-S        1 .757** .692** 
DASS21-A         1 .740** 
DASS21-D          1 
Note: SSCI, Stigma Scale for Chronic Illness; COPE-M, COPE/Maladaptive subscale; COPE-A, COPE/Adaptive subscale; 
CDIP-58, Cervical Dystonia Impact Profile; WEMWBS, Warwick-Edinburgh Mental Wellbeing Scale; DASS21-S, Depression 
Anxiety Stress Scale/Stress subscale; DASS21-A, Depression Anxiety Stress Scale/Anxiety subscale; DASS21-D, Depression Anxiety 
Stress Scale/Depression subscale. 
*p<0.05 
**p<0.01 





Parallel Mediation Models 
Table 2-5 
Parallel Mediation Models 
 Model 1 
X = stigma 





Y = HRQoL 
Model 2 
X = stigma 





Y = wellbeing 
Model 3 
X = stigma 





Y = stress 
Model 4 
X = stigma 





Y = anxiety 
Model 5 









a1 .003 .003 .003 .003 .003 
a2 .246*** .246*** .246*** .246*** .246*** 
b1 -.456 .372*** -.020 -.030 -.135** 
b2 2.006** -.549** .371*** .308*** .489*** 
c’ 1.367*** -.194** .061* .091** .091** 
c 1.859*** -.328*** .152*** .167*** .210*** 
a1b1 -.001 .001 <.001 <-.001 <-.001 
CI -.060, .074 -.037, .038 -.004, .005 -.005, .005 -.016, .014 
a2b2 .492^ -.135^ .091^ .076^ .120^ 
CI .136, .857 -.231, -.050 .050, .137 .035, .116 .075, .172 
CSIE1 -.001 .002 <-.001 <-.001 -.001 
CI -.021, .026 -.062, .060 -.015, .019 -.018, 017 -.047, .041 
CSIE2 .177^ -.219^ .327^ .264^ .370^ 
CI .051, .306 -.369, -.084 .184, .477 .122, .400 .237, .517 
*p < 0.05, **p < 0.01, ***p<0.001 
^ Significant indirect effect with 95% CI 
1 = adaptive coping as mediator 
2 = maladaptive coping as mediator 
Note: X=predictor, M=mediator and Y=outcome; c’ = direct effect of X on Y, controlling 
for M; c = total effect of X on Y; ab = mediated effect; CI = confidence interval; CSIE: 
completely standardised indirect effect.  





























3 b1 = -.456
b2 = 2.006**
C’ = 1.367***
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Figure 2-2. Parallel Mediation models (unstandardized).  
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This critical appraisal will start by summarising the main findings of both the literature 
review and the research paper.  It will also highlight the novel contribution of this research to the 
field of knowledge regarding psychological distress in dystonia.  Following the summary, it will 
reflect on some of the decisions that were made throughout the project as well as considering the 
rationale for some of this.  Within this is makes some suggestions for future research and 
highlights some of the ways the current project could have been improved on. 
Main Findings 
Systematic literature review 
The systematic literature review examined the relationship between anxiety and 
depression and other psychological factors for those living with dystonia. Results were 
synthesized from 16 quantitative research papers. The findings suggested that psychological 
factors such as body image, coping styles, self-efficacy, personality traits and self-esteem were 
correlated with anxiety and/or depression in this population. There was also emerging evidence 
in the form of single studies which suggested that substance abuse, locus of control, sexual 
wellbeing and social support may also be correlated with anxiety and/or depression for this 
population. Overall there was a limited amount of research that had focussed on psychological 
factors relating to distress in dystonia, but it was clear that these were worthy of more 
consideration in future research and highlighted the need to do so. This also had clinical 
implications for the management of distress when working with this population.  
Main paper 
The main paper was underpinned by a theoretical ‘psychological mediation framework’ 
model which proposes that the impact on psychological wellbeing from the stress related to 
stigma is mediated by the strategies a person uses to cope with such stress (1). This framework 




was examined through the use of parallel mediational models with stigma as a predictor and with 
adaptive and maladaptive coping strategies as the mediator variables. Outcome variables were 
anxiety, depression, stress, health related quality of life (HRQOL) and wellbeing. A series of 
correlational analyses were also conducted to examine any potential relationships between the 
variables.   
The results of the analysis suggested that higher levels of stigma were related to higher 
levels of distress, lower levels of wellbeing and lower HRQOL for people living with cervical 
dystonia. High levels of stigma were also related to more frequent use of maladaptive coping 
strategies but not to the use of adaptive coping strategies. A higher frequency of using 
maladaptive coping strategies was related to increased levels of distress, lower levels of 
wellbeing and lower HRQOL. A higher frequency of adaptive coping strategies was only found 
to be related to an increase in wellbeing. The mediation analysis identified an indirect effect of 
stigma on all the outcomes through maladaptive coping. Adaptive coping did not mediate the 
relationship between stigma and any of the outcomes. These findings provided partial support for 
the psychological mediation framework. 
One of the strengths of this research was that it produced some novel findings that can be 
added to the developing understanding of the psychological impact of living with cervical 
dystonia, as well as support for the theoretical psychological mediation framework (1). Although 
this model has been examined in the context of sexual and gender minorities (2), mental health 
(3) and HIV (4), this study was the first time that it had been applied to those with a physical 
health condition which involves a visible difference. In addition, although stigma has previously 
been examined in relation to HRQOL (5), this is the first study to directly examine the 




relationship between stigma and distress and wellbeing in this population. It is also the first to 
examine wellbeing in relation to other psychological factors in those with CD.  
Clinical implications for thorough psychological formulations for people living with 
dystonia were identified, particularly due to the high reports of stigma in this cohort and the 
findings suggesting that maladaptive coping strategies may be related to the distress people 
experience as a result of being stigmatized. However, it was also discussed how adopting a more 
nuanced approach to the concept of coping strategies may help to further understand the 
complexities of their role in the development and maintenance of distress.  This is discussed in 
more detail below but may include alternative categorisations of coping or qualitative research to 
further explore individual’s experience of coping with the stress of stigma. The high rates of 
stigma reported in this study also highlight the importance of addressing societal attitudes on a 
more systemic level.  Particularly as other research has highlighted that others show stigmatising 
attitudes to those with dystonia (6). 
 
Decision-making, challenges and opportunities for improvement 
Throughout this piece of work there were many points where decisions had to be made 
that could have influenced its direction. I will therefore reflect on some of these below.  
Systematic literature review 
Research question 
Attempting to formulate a research question for the systematic review was initially 
challenging. Research into dystonia has a strong medical focus and I was keen to bring my own 
interest of the role of clinical psychology in neurological conditions to this area. The challenge 
came from defining a question which was narrow enough to be able to effectively synthesise the 




results from multiple papers, whilst also being broad enough to account for the limited 
psychological research that has traditionally been carried out with this population. An 
examination of the history of our understanding of dystonia suggests that the focus of 
psychological difficulties as a ‘cause’ of the condition has thankfully been gradually abandoned 
in favour of a more neurophysiological understanding, despite the mechanisms still not being 
fully understood (7). However, this has meant that the psychological distress commonly 
experienced by those with dystonia is often viewed as resulting from changes in the brain (8). 
Consideration of other psychosocial factors involved in the development and maintenance of 
psychological distress, although examined more extensively in other neurological disorders (9), 
has not had as much attention in dystonia. I had hoped that looking at psychological correlates of 
anxiety and depression in dystonia might help to bring focus onto other factors which may be 
involved in the development and maintenance of distress for those living with the condition, 
which in turn can be considered within clinical practice.  
I made the decision to focus the research on idiopathic dystonia (which has no clear 
cause) as this is the most common presentation (10). Even within this category, there are many 
different presentations and there is research suggesting that there are differences in the 
experience of distress based on the location of the dystonia (11). As this is an already complex 
area, I made the decision to exclude studies which focussed on those who experienced dystonia 
as a side effect of taking psychiatric medications, or those where dystonia was secondary to 
another condition such as traumatic brain injury, as I felt that these would add extra complexity 
to an already complex area which was beyond the scope of this review.  





I believe that my decision to keep my search strategy broad to increase sensitivity, and 
opt instead to manually screen a higher number of articles, was the right one to make to maintain 
the balance between sensitivity and specificity (12). Keeping the focus of the search simple to 
include only terms relating to ‘dystonia’, ‘anxiety’ and ‘depression’ meant that studies which 
included other psychological factors could be captured, even if these were not the main focus of 
the research. Additionally, distress in dystonia is conceptualised more as a ‘psychiatric’ difficulty 
than a ‘psychological’ one, so narrowing the search further to specify psychological factors may 
have meant that studies that were relevant would have been missed. The use of diagnostic 
language for psychological distress does not necessarily fit with my own, and some others’, 
views on diagnostic labels (13). However, this being an under researched area in a predominantly 
medical field, meant that adopting these terms for this project would mean that I accessed the 
largest pool of potential studies for inclusion in the review. In addition, as dystonia is typically 
understood and researched under the medical model and publications are often in medical, rather 
than psychological journals, using databases that covered both of these areas increased the 
chances of relevant papers being found. 
Research paper 
Survey design and measures 
Early on in the development of my empirical study, decisions had to be made concerning 
the measurement of key variables and the design of the online survey.  A number of factors 
needed to be considered for the measures such as length, availability, reliability and validity. One 
of the strengths of this study was the contribution of two people with lived experience of cervical 
dystonia. Having their input on the proposal and survey design was invaluable, they were able to 




make suggestions to improve on the language used to describe each of the measures, making it 
clearer  and more accessible to those filing out the surveys. There were suggestions made on the 
wording of specific items within measures which I was unable to action as this would have 
impacted on the overall reliability. However, I was able to feedback to both individuals regarding 
the changes that were and were not made and the reasons for doing this. 
As was found in my literature review, there have been a number of different measures 
used to look at psychological distress in those living with dystonia, but these are all general 
measures which have not been validated for use with this population. The issue here was that 
there were no measures that had been specifically validated for use with dystonia. The Becks 
Depression Inventory (BDI) (14) was a measure that had been commonly used in the research, 
although I felt that this would add too much length to the overall questionnaire when used 
alongside the other measures. There was some consideration given to the Hospital Anxiety and 
Depression Scale (HADS) (15), particularly as this has been suggested as a suitable screening for 
anxiety and depression in Parkinson’s disease, which also has a motor component (16). However, 
as the underlying theoretical model that the research question was based on had an emphasis on 
stigma as a stressor, I made the decision to use the short version of the Depression Anxiety Stress 
Scale–21 (DASS-21) as this also included a subscale measuring levels of stress (17,18). I 
assessed it as being user friendly and it had been used in other studies involving movement 
disorders (19,20). The limitation from using this measure is that it had not specifically been used 
in dystonia before, so it was difficult to draw comparisons with previous research. In addition, 
the anxiety subscale of the DASS-21 has been found to be problematic in people with 
Parkinson’s disease, another movement disorder with some similar features (21).  However, this 
was more related to tremor so might be less relevant to this population. As results were similar 




across the different outcome measures in my study, this may not have been problematic in the 
same way it has been in Parkinson’s disease.  
As there has only been limited research to date into the experience of psychological 
distress for those living with cervical dystonia, future research will need to further explore which 
measures accurately capture anxiety and depression in this population. One option would be to 
use the DASS-21 alongside other validated measures, such as the HADS or BDI, which have 
been utilised more extensively in dystonia and would be able to serve as a comparison. This 
would be more appropriate if there were fewer variables/measures included in the research 
design. It would also be useful for a comprehensive review and critique of the available measures 
to be conducted in relation to dystonia as this has not been carried out to date.  
HRQOL was included alongside distress and wellbeing as an outcome measure to 
provide a more holistic picture of ‘psychological wellbeing’. This was one variable for which 
there were two measures specifically designed for those with cervical dystonia: the Cervical 
Dystonia Impact Profile (CDIP-58) (22) and the Craniocervical Dystonia Questionnaire (CDQ-
24) (23). Out of these the CDQ-24 would have been more preferable from a length perspective. 
However, it specifically includes a stigma subscale which may have inflated any findings of a 
relationship between stigma and quality of life. The CDIP-58 was longer and did not have stigma 
as a subscale, although there were stigma related items within the psychosocial functioning scale. 
The decision to use the CDIP-58 was based on the increased level of sensitivity in this 
population (24). It has also been found to correlate well with comparable subscales of the 
Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36) (25) (24).   
The SF-36 is a more generic health status measurement and has been used to assess 
HRQOL in previous dystonia studies (26). It has been recommended that both disease-specific 




and generic measures should be used (27), which allows for a more complete picture of the 
impact of a condition, as well as being able to draw comparisons across the research with other 
conditions. Due to the length of the survey the decision to use one rather than two quality of life 
measures was taken. It may be pertinent for future research to use both types of measures to 
further understand the impact of stigma and coping styles on HRQOL. If this is done, the SF-36 
is a good option as a general measure. Care should be taken though, as the computation of 
summary scores into a physical component score (PCS) and mental component score (MCS) as 
proposed by the original authors of the measure may not be suitable for those with cervical 
dystonia. A factor analysis carried out on the SF-36 found that the subscales of ‘social 
functioning’ and ‘vitality’, traditionally included in the MCS, were more strongly related to the 
PCS in cervical dystonia (28). Another consideration when using this measure is that the ‘role 
physical’ and ‘role emotional’ subscales had large floor and ceiling effects which can risk any 
clinical change being underestimated (28). However, this adds strength to the proposal of using a 
disease specific measure alongside, which may be more sensitive to changes within a specific 
condition.  
With hindsight, the use of the CDIP-58 is one of the decisions that I may reconsider if 
replicating this study. The main reason for this was the length of the measure and the overall time 
it added to the survey. Although I had involvement from two individuals in the design of the 
project who had found the survey length manageable, once I had collected the data, there were a 
number of people who had not completed all the measures. I was unable to gather feedback from 
participants due to the anonymity of the survey, however, I hypothesised that the length may 
have been a factor in non-completion. This impacted on the amount of data available for analysis 
and risked the results being more biased towards those who were more able. I would suggest that 




using the CDQ-24 alongside a further analysis to explore any impact of the stigma scale on the 
overall results, may make the survey more accessible to people.  
The concept of coping and use of language 
Throughout the process of designing, conducting and writing up my research paper, I 
have had several decisions to make around the inclusion of the concept of coping, including how 
to measure it, how to classify it, and how to name it. Some of the decisions have been quite 
difficult and, I feel, guided more by the aims and intended audience of the research rather than 
necessarily being reflective of my own values and beliefs. Coping itself is a difficult construct to 
conceptualise, with many differing descriptions and ways of measuring it within the literature 
(29). My literature review identified that it had been examined in the context of dystonia 
previously (30–33) and one of the measures used was the Ways of Coping Checklist (34). 
However, this is a 66-item measure, and as mentioned, I needed to consider the overall length 
and accessibility of the survey. Instead I opted for the Brief Cope (35).  This was a more 
manageable length of 28 items covering 14 different subscales and was a validated way of 
measuring state coping strategies. It had also been used in other movement disorders such as 
Parkinson’s disease and multiple sclerosis (36,37). In addition, it had been used in another study 
that examined the psychological mediation framework, which was underpinning my research, 
albeit with a cohort of students rather than in physical health. 
Once I had chosen my scale then I needed to make a decision on the categorisation of the 
subscales. The measure has mainly been categorised in two ways: a two-factor categorisation 
(adaptive and maladaptive) and a three-factor categorisation (emotion focussed, problem 
focussed and dysfunctional).   




I originally considered the three-factor categorisation, although felt that separating 
emotion-focussed coping and problem-focussed coping may be problematic. It has been 
suggested in the coping research that problem focussed coping strategies may be more adaptive 
than emotion focussed strategies (38,39). However, if a condition is chronic and there is no cure, 
individuals may feel that they have little control over the stressor and turn towards emotion-
focussed rather than problem-focussed coping strategies (40). It has also been highlighted that 
problem-focussed strategies are more appropriate for controllable stressors and emotion-focussed 
strategies are more adaptive if the stressor is outside of an individual’s control (41). There is also 
the issue that emotion focussed and problem focussed coping are not conceptually clear and most 
ways of coping could potentially fit into both categories (29). Therefore, as the scope of this 
study was to test the theoretical model for the first time in a novel area, a broader 
conceptualisation of coping strategies within the two-factor model felt more practical. This is 
also in line with other research that has used the theoretical model and same coping measure 
within a student population (3). 
There are limitations to the two-factor categorisation that need to be considered. For 
example, ‘religious coping’ is included within the adaptive coping category. However, there have 
been mixed findings in the research with some supporting it as an adaptive strategy (42) and 
others (including in dystonia research) finding that it is a maladaptive strategy (31). For future 
research it would be worth looking at the individual subscales when analysing their mediating 
role in the relationship between stigma and psychological wellbeing. Another option would be to 
draw on a strategy used by Jahanshahi (31). Prior to entering maladaptive and adaptive coping 
into a regression model, they checked the correlations between the individual subscales and 
grouped them based on their relationship to a measure of depression. Although this 




categorisation may limit the generalisability to the wider population, it would give a clearer idea 
of what coping styles may be adaptive or maladaptive for the specific group being studied. This 
could also be explored through qualitative research, examining how those living with dystonia 
cope with any stress associated with stigmatising experiences. Enhancing understanding around 
these concepts could then inform how coping is examined and categorised within quantitative 
research.  
Despite the complexities of classification of coping, there is some agreement the 
‘maladaptive’ and ‘adaptive’ are appropriate second-order dimensions (43,44), although I found 
the term ‘maladaptive’ did not fit with my own understanding of coping strategies. Further 
reading around classifications of coping styles revealed other descriptors such as ‘problematic’ 
and ‘dysfunctional’ which posed the same issues for me. These terms felt pathologizing and 
blaming, whereas a more nuanced understanding of coping strategies would recognise that there 
are times that even ‘maladaptive’ strategies would be adaptive and serve a purpose, and that 
strategies are not necessarily used in isolation of each other (45). Upon reflection I made the 
difficult decision to keep the wording, as this is the language that is used within the coping 
literature (43) and has also been used previously when looking at coping in dystonia(31). 
However, I may reconsider this if I was to replicate the research or examine coping styles in the 
future.  One option would be to consult with those with lived experience and to include their 
thoughts and feelings on the terms used to describe the different coping strategies. 
Conclusion 
This project highlighted the importance of considering psychological approaches for 
people living with dystonia. Research within this area appears to be limited and with a focus on 
pathophysiological understandings of distress associated with this condition. The current review 




of the literature and research paper revealed that there are other psychological factors involved 
with the distress experienced by those with dystonia. More research is needed employing a range 
of methodological designs (e.g. longitudinal, qualitative) to further understand the experiences of 
concepts such as stigma and coping, and how these factors interrelate in dystonia. An increase in 
our understanding of these will better enable clinicians to support the psychological wellbeing of 
people with dystonia.  
Within this project there was numerous points where important decisions had to be made 
on how to proceed. One of the strengths of this was the involvement of people with lived 
experience of cervical dystonia and future research should strive to include this where feasible. 
When examining a number of different theoretical concepts (e.g. stigma, coping, quality of life) 
within a single research design, there will always be limitations due to the complexities of these 
areas and decisions have to be made to balance the number and length of measures against the 
accessibility for those agreeing to take part. On the whole I feel that most of the decisions I made 
were the right ones for this project. The main considerations I would give if repeating this 
research would be to use a shorter measure of disease specific quality of life, and maybe add a 
generic health impact measure such as the SF-36. I would also consider exploring different 
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are in the proposed study?  Are there any matters about which you wish to seek guidance from the 
FHMREC? 





SECTION FOUR: signature 
 
Applicant electronic signature: Helen Gowling      Date 09.08.19 
Student applicants: please tick to confirm that your supervisor has reviewed your application, and that 
they are happy for the application to proceed to ethical review   




1. Submit your FHMREC application by email to Diane Hopkins 
(fhmresearchsupport@lancaster.ac.uk) as two separate documents: 
i. FHMREC application form. 
Before submitting, ensure all guidance comments are hidden by going into ‘Review’ in 
the menu above then choosing show markup>balloons>show all revisions in line.   
ii. Supporting materials.  
Collate the following materials for your study, if relevant, into a single word 
document: 
a. Your full research proposal (background, literature review, 
methodology/methods, ethical considerations). 
b. Advertising materials (posters, e-mails) 
c. Letters/emails of invitation to participate 
d. Participant information sheets  
e. Consent forms  
f. Questionnaires, surveys, demographic sheets 
g. Interview schedules, interview question guides, focus group scripts 
h. Debriefing sheets, resource lists 
 
Please note that you DO NOT need to submit pre-existing measures or handbooks which 
support your work, but which cannot be amended following ethical review.  These should 
simply be referred to in your application form. 
2. Submission deadlines: 
i. Projects including direct involvement of human subjects [section 3 of the form was 
completed].  The electronic version of your application should be submitted to Becky 
Case by the committee deadline date.  Committee meeting dates and application 





may be contacted by the lead reviewer for further clarification of your application. 
Please ensure you are available to attend the committee meeting (either in person or 
via telephone) on the day that your application is considered, if required to do so. 
ii. The following projects will normally be dealt with via chair’s action, and may be 
submitted at any time. [Section 3 of the form has not been completed, and is not 
required]. Those involving: 
a. existing documents/data only; 
b. the evaluation of an existing project with no direct contact with human 
participants;  
c. service evaluations. 
3. You must submit this application from your Lancaster University email address, and copy your 







2 Study Protocol 





Trainee Clinical Psychologist, Doctoral Student in Clinical Psychology (DClinPsy) 
Room C34, Furness College, Lancaster University, Lancaster, LA1 4YG 
Tel:  44 (0)7913203650, email: h.gowling@lancaster.ac.uk 
 
Research Supervisor 
Dr Fiona Eccles 
Lecturer in health research, Lancaster University, Lancaster, LA1 4YT, UK 
Tel: 44 (0)1524 592807, email: f.eccles@lancaster.ac.uk 
 
Field Supervisor 
Dr Fiadhnait O’Keeffe 
Senior Clinical Neuropsychologist, St. Vincent’s University Hospital, Elm Park, Dublin 








Dystonia is a movement disorder which involves repetitive movements and abnormal 
postures caused by sustained muscle contractions (Lewis, Butler, & Jahanshahi, 2008). Studies 
have shown that it affects approximately 0.01-0.03% of the population (Phukan, Albanese, 
Gasser, & Warner, 2011) The effects of the visible changes to appearance have been associated 
with embarrassment which can lead to psychological difficulties, social avoidance, and isolation 
(Lewis et al., 2008).  Cervical dystonia, also known as spasmodic torticollis, is the most common 
kind of focal dystonia (a type of dystonia that affects one part of the body) and is characterised 
by uncontrolled twisting, turning and tilting of the head caused by involuntary and often painful 
contractions of the neck muscles (Ben-Shlomo, Camfield, & Warner, 2002). 
One focus of research in this population has been health related quality of life (HRQOL) 
(Weiss et al., 2017).  This broadly looks at how a condition impacts on an individual across 
physical, social and psychological domains (Calvert & Freemantle, 2003; Hays, Hahn, & 
Marshall, 2002).  The research suggests that depression (Basurović, Svetel, Pekmezović, & 
Kostić, 2012), negative body concept (Pekmezovic et al., 2009) and social participation (Ben-
Shlomo et al., 2002) are some of the main factors correlated with HRQOL.  In studies of other 
movement disorders, such as Parkinson’s Disease, stigma has also been found to play a key role 
in HRQOL (Ma, Saint-Hilaire, Thomas, Tickle-Degnen, & Thomas, 2016) 
Stigma is a vital aspect of health research.  Visible characteristics, such as tremors or 
muscle contractions in dystonia, can result in stigmatising social experiences alongside the 
physical and emotional impact of the condition (Joachim & Acorn, 2000). Psychological, 
physical and social aspects of illness can be exacerbated by the emotional impact of social 
disqualification (Weiss, Ramakrishna, & Somma, 2006).    Stigma relating to a condition may 





Stigma can be broken down into two main areas: enacted stigma which is related to 
discrimination and attitudes from the public; and perceived stigma which is an internalising of 
enacted stigma by an individual, often leading to feelings of shame (Goffman, 1963).  Perceived 
stigma has also been shown to lead to a poorer quality of life, negatively impact health related 
outcomes and increase social isolation in people with mental health difficulties (Fung, Tsang, & 
Corrigan, 2008; Rüsch & Corrigan, 2010; Rüsch et al., 2006).  Studies of enacted stigma with 
populations of people with epilepsy show that frequency of enacted stigma is associated with 
increased psychological distress and a poorer quality of life (Kumari, Ram, Haque Nizamie, & 
Goyal, 2009; McLaughlin, Pachana, & McFarland, 2008; Suurmeijer, Reuvekamp, & 
Aldenkamp, 2001).  Stigma has also been found to predict psychological outcomes in people 
with neurological conditions which present with movement disorders such as Parkinson’s disease 
and multiple sclerosis (Gallagher, Lees, & Schrag, 2010; Valvano et al., 2016). 
The role of stigma in psychological outcomes for people with dystonia is poorly 
understood.  One study found a significant relationship between stigma and both the mental and 
physical aspects of quality of life in people with cervical dystonia (Ben-Shlomo et al., 2002).  
Another study found no significant relationship between stigma and health related quality of life 
for people with segmental dystonia (Basurović et al., 2012), however this study had a small 
sample size.  Both studies also used a stigma scale designed for people with bowel cancer 
(MacDonald & Anderson, 1984).  A 2001 study examining the role of stigma in cervical dystonia 
found that the majority of participants had felt some, or severe stigma (Papathanasiou, 
MacDonald, Whurr, & Jahanshahi, 2001).  The questionnaire used in the 2001 study was created 
following interviews with participants. Although this meant that it had good face validity and 





generalisable this could be to other people living with dystonia.  An additional study looking at 
the perceptions of people without dystonia showed stigmatising attitudes towards those with 
cranial and cervical dystonia (Rinnerthaler, Mueller, Weichbold, Wenning, & Poewe, 2006), 
suggesting that enacted stigma is very much a part of daily life for this population, particularly 
those with cervical dystonia. 
Research focussed on other groups who experience stigma draws heavily on the minority 
stress paradigm (Meyer, 2003), which conceptualises stigma as a stressor above and beyond what 
non-stigmatised people endure, which then leads to difficulties with mental health.  This was 
further developed into a psychological mediation framework (Hatzenbuehler, 2009) which 
integrated the theory of minority stress with psychological processes that may result from being 
stigmatised, and therefore contribute to psychological distress.  One of these proposed processes 
was coping styles.  There is emerging evidence that the experience of stigma can lead to coping 
behaviours which could be considered maladaptive, such as disengagement and substance use, 
which in turn can impact on psychological wellbeing and quality of life (Hatzenbuehler, Phelan, 
& Link, 2013).  To date the relationship between stigma, coping styles and psychological 
outcomes has not been examined in people with dystonia.   
Consequently, this study will investigate the relationship between stigma and 
psychological outcomes then also investigate whether coping mediates this relationship in a 
cohort of people with cervical dystonia.  The focus will be on people with cervical dystonia as 
this is the most common type of dystonia.  If stigma and coping are found to be a significant 
factor for distress and wellbeing, then this would have implications for the field of clinical 





interventions and, in turn, potentially lead to improved psychological well-being for those with 
cervical dystonia.  
Method: Participants 
For a medium effect (0.36) in both paths (stigma to control (α) and control to 
psychological outcomes (β)) using a bias-corrected bootstrap mediation model, approximately 71 
participants are required for 80% power, rising to 115-116 if the α or β path coefficient has a 
small-medium effect (0.26) (Fritz & MacKinnon, 2007). Previous research looking at the 
relationship between stigma and coping have found small-medium effects for adaptive coping 
and large effects for maladaptive coping, suggesting powering the study for a small-medium 
effect should be sufficient (Tran & Lumley, 2019). It is not possible to take the effect size for β 
from previous research as this requires the identical model (and we are not aware of such 
research). However, the study will be powered so that it should find a small-medium effect 
should it exist (at 80% power). Thus, in total the aim would be to recruit 116 participants 
Inclusion criteria 
• Individuals who self-report a diagnosis of cervical dystonia  
• aged 18 or over. 
• Individuals who are able to complete the measures alone or with support. 
• The questionnaire will be written in English, so individuals will need to have sufficient 
understanding of written English to take part. 
Exclusion criteria 
• Potential participants will be excluded if they have dystonia following a serious injury,  
• Potential participants who also have other significant illness/condition that affects their 






The study will be a cross-sectional survey using quantitative measures. The data will be 
quantitatively examined and a mediation analysis will be conducted using Hayes process tool 
(Hayes, 2013) within SPSS to examine whether coping style mediates the relationship between 
stigma and psychological wellbeing (including distress) and quality of life. 
The dependent variables will be scores of emotional wellbeing, distress, and quality of 
life: The short version of the Depression Anxiety Stress Scale – 21 (DASS-21) (Henry & 
Crawford, 2005; Lovibond & Lovibond, 1995), the Warwick-Edinburgh Mental Well-being Scale 
(WEMWBS) (Tennant et al., 2007), and the Cervical Dystonia Impact Profile (CDIP-58) (Cano 
et al., 2004)which assess quality of life will be used. – see materials section for details on 
reliability and validity.  
The predictor variable will be perceived stigma, measured using the Stigma Scale for 
Chronic Illness (SSCI-8) (Rao et al., 2009).  The mediating variable will be coping style which 
will be measured using the brief COPE (Carver, 1997) using the two-category model developed 
by Meyer (2001)which divides the subscales into adaptive and maladaptive coping strategies. 
 
Method: Materials 










• Work status 
• Relationship status 
• Living arrangements 
Clinical variables 
• Age of onset 
• Duration 
• Time since diagnosis 
• Medication 
• Botulinum toxin (BTX) treatment  
• Other treatments 
• Other health conditions 
Validated measures 
• The short version of the Depression Anxiety Stress Scale – 21 (DASS-21) (Henry & 
Crawford, 2005; Lovibond & Lovibond, 1995).  This is a 21-item scale.  Although not 
used specifically with people living with dystonia, it has been used with other 
neurological conditions which present with movement disorders such as Parkinson’s 
disease (Birtwell, Dubrow-Marshall, Dubrow-Marshall, Duerden, & Dunn, 2017) and 
multiple sclerosis (Solaro, Gamberini, & Masuccio, 2018). 
• The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) (Tennant et al., 2007) is 
a 14-item validated measure of wellbeing which focusses on positive aspects of mental 
health.  Although not researched specifically with physical health populations, it is 






• Quality of Life will be measured using the Cervical Dystonia Impact Profile (CDIP-58) 
(Cano et al., 2004) which is a 58-item scale measuring the impact of CD across eight 
domains: head and neck symptoms, pain and discomfort, upper limb activities, 
annoyance, sleep, walking, mood and psychosocial functioning. This measure has been 
shown to have good validity and reliability (Cano et al., 2008). 
• Stigma will be measured by the 24-item Stigma Scale for Chronic Illness (SSCI).  This 
scale was developed for people with chronic neurological disorders and measures both 
felt stigma and enacted stigma (Rao et al., 2009).  It has been shown to have fair internal 
consistency and good content validity (Stevelink, Wu, Voorend, & van Brakel, 2012). 
• Coping styles will be measured using the brief COPE (Carver, 1997).  This has 14 scales 
with each subscale including two items.   Although this has been categorised in various 
ways in the literature, this study will use the two-category model developed by Meyer 
(2001) which divides the subscales into adaptive and maladaptive coping strategies. 
• Disease Severity will be measured using the Functional Disability Questionnaire 
(Jahanshahi & Marsden, 1990).  This is a 27-item scale developed to measure the impact 
of dystonia on activities of daily living.  The construct and concurrent validity of the 
scale, along with test-retest reliability and internal consistency were shown to be high 
(Jahanshahi & Marsden, 1990). 
 Method: Procedure 
This project will be advertised through the UK Dystonia Society 
(https://www.dystonia.org.uk/) and Dystonia Ireland (http://www.dystonia.ie/) via any channels 
available to them (e.g. website, social media, newsletter, groups, posters) and using both an 





on the webpage to provide people with the relevant contact information.   Other dystonia relevant 
online organisations may also be approached to request the advert be shared through their 
channels. It will also be shared on the Lancaster University Doctorate in Clinical Psychology 
webpage and social media. An advert will be provided however the charities will be free to add 
their own wording when sharing details of the study with their members (see appendix 12 for 
advert). Individuals will read information about the purpose of the study before being directed to 
a consent page if they wish to take part (see appendices 1 and 2 for participant information and 
consent form- paper version).  Once consent has been provided to take part in the research the 
online survey will appear (see appendix 11 for link to online version of the survey).  If 
participants would prefer to complete the survey in paper format, the information page and initial 
advert will include contact details and instructions on how to access a paper copy.  Paper copies 
of the survey will be provided if participants choose to complete the survey in this format.  At the 
end of the study participants will be provided with a debrief, information on how they can be 
entered into a prize draw in return for taking part, and details of support resources as provided in 
the initial information will be repeated (see appendix 10 for paper version of debrief).  The 
survey should take approximately 30 minutes to complete.  Data from the online survey will be 
gathered electronically, and data from the hard copies will be inputted immediately into the 
electronic dataset.  The hard copies of the questionnaire will be safely and immediately 
destroyed.   
Proposed analysis 
A series of mediation analyses using Hayes PROCESS tool (Hayes, 2013) within SPSS 







For participants who would prefer to access the survey in paper format, an additional cost 
of postage will be incurred. This will be funded by the DClinPsy course at Lancaster University. 
Ethical concerns 
Participating in this study should not pose a significant risk to participants.  However, 
reflecting on the issues raised within the research may be difficult for some people.  Contact 
details will be provided of places that can be provide support should any issues arise.  
Additionally, it will be made clear prior to starting the study that they can stop at any time during 
the survey although, due to the anonymity of participation, their data cannot be removed after 
they have agreed to take part. 
Service User Involvement 
Two experts by experience have been consulted on the measures used within the survey 
and the design of the project.  Changes were then made following feedback. 
Timescale 
Ethics application: 10th July 2019 
Recruitment  September 2019- January/Feb 2020 
Analysis and write up February- April 2020 
Submission   May 2020 
Appendices 
Appendix1: Participant information sheet. – paper version 
Appendix 2: Participant consent form. – paper version 
Appendix 3: Demographic and Clinical information – paper version. 
Appendix 4: Stigma Scale for Chronic Illness (SSCI-24) (Rao et al., 2009) – paper 
version. 





Appendix 6: Cervical Dystonia Impact Profile (CDIP-58) (Cano et al., 2004) – paper 
version. 
Appendix 7: Warwick-Edinburgh Mental Well-being Scale (WEMWBS) (Tennant et al., 
2007)- paper version. 
Appendix 8: Depression Anxiety Stress Scale – 21 (DASS-21) (Henry & Crawford, 2005; 
Lovibond & Lovibond, 1995) – paper version. 
Appendix 9: Functional Disability Questionnaire (FDQ) (Jahanshahi & Marsden, 1990) – 
paper version.  
Appendix 10: Participant debrief – paper version 
Appendix 11: link to online survey 
Appendix 12: Advertisement for recruitment 
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Applicant: Helen Gowling 
Supervisor: Fiona Eccles 
Department: Health Research 
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Re: Stigma, coping styles and wellbeing in individuals with cervical dystonia     
 
Thank you for submitting your research ethics application for the above project for review by 
the Faculty of Health and Medicine Research Ethics Committee (FHMREC). The application 
was recommended for approval by FHMREC, and on behalf of the Chair of the Committee, I 
can confirm that approval has been granted for this research project.   
 
As principal investigator your responsibilities include: 
- ensuring that (where applicable) all the necessary legal and regulatory requirements 
in order to conduct the research are met, and the necessary licenses and approvals 
have been obtained; 
- reporting any ethics-related issues that occur during the course of the research or 
arising from the research to the Research Ethics Officer at the email address below 
(e.g. unforeseen ethical issues, complaints about the conduct of the research, adverse 
reactions such as extreme distress); 
- submitting details of proposed substantive amendments to the protocol to the 
Research Ethics Officer for approval. 
 
Please contact me if you have any queries or require further information. 
 













Appendix 4-2 Amendment application 
 
 
Faculty of Health and Medicine Research Ethics Committee (FHMREC) 
Lancaster University Application for Amendment to 
Previously Approved Research 
 
 
1. Name of applicant:  
2. E-mail address and phone number of applicant: 
3. Title of project: 
4. FHMREC project reference number: 
5. Date of original project approval as indicated on the official approval letter 
(month/year): 
6. Please outline the requested amendment(s) 
Helen Gowling 
h.gowling@lancaster.ac.uk 
07913203650   








Note that where the amendment relates to a change of researcher, and the 
new researcher is a student, a full application must be made to FHMREC 




a) Resubmit your research ethics documents (the entire version which received final 
approval, including all participant materials, your application form and research 
protocol), with all additions highlighted in yellow, and any deletions simply ‘struck 
through’, so that it is possible to see what was there previously. 
b) This should be submitted as a single PDF to Becky Case There is no need to 
resubmit the Governance Checklist 
 
Expansion to recruitment strategy to include: 
Video to advertise the study on the websites of both Dystonia Ireland and the Dystonia 
Society. 
For both charities to be able to be able to advertise through all channels available to them 
(i.e posters, newsletter, cascading to local groups) 
Other dystonia relevant online organisations may also be approached to request the advert 
be shared through their channels. 
 
Following discussions with the Dystonia Society, they requested the video to be put on 
their website and suggested advertising in non-electronic ways as the people who access their 
service and may wish to participate in research do so in a variety of ways rather than just on 
social media.  This also justifies expanding the recruitment to other dystonia relevant 






Applicant electronic signature:   Date 
 
Student applicants: please tick to confirm that you have discussed this amendment 
application with your supervisor, and that they are happy for the application to proceed 
to ethical review  ☒ 
 
Project Supervisor name (if applicable): Date application discussed 
 
You must submit this application from your Lancaster University email address, 
and copy your supervisor in to the email in which you submit this application 
 
  
Helen Gowling 07/10/2019 









Applicant: Helen Gowling 
Supervisor: Fiona Eccles 
Department: Health Research 
FHMREC Reference: FHMREC19013 
 





Re: Stigma, coping styles and wellbeing in individuals with cervical dystonia 
 
Thank you for submitting your research ethics amendment application for the above project 
for review by the Faculty of Health and Medicine Research Ethics Committee (FHMREC). The 
application was recommended for approval by FHMREC, and on behalf of the Chair of the 
Committee, I can confirm that approval has been granted for the amendment to this research 
project.  
 
As principal investigator your responsibilities include: 
- ensuring that (where applicable) all the necessary legal and regulatory requirements 
in order to conduct the research are met, and the necessary licenses and approvals 
have been obtained; 
- reporting any ethics-related issues that occur during the course of the research or 
arising from the research to the Research Ethics Officer at the email address below 
(e.g. unforeseen ethical issues, complaints about the conduct of the research, adverse 
reactions such as extreme distress); 
- submitting details of proposed substantive amendments to the protocol to the 
Research Ethics Officer for approval. 
 
Please contact me if you have any queries or require further information. 
 




































































































































































Appendix 4-5: Recruitment advert 
 
 
